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ZUSAMMENFASSUNG 
 
Die Parkinsonsche Krankheit ist die zweithäufigste neurodegenerative 
Erkrankung. Die Haupt-Symptome sind Tremor (unkontrolliertes Zittern) 
und maskenhafte Gesichtszüge. Auf zellulärer Ebene geht die Krankheit 
einher mit fortschreitendem Verlust von Neuronen der Substantia nigra 
im Zentralnervensystem. Die meisten Fälle sind idiopathisch, d.h. ohne 
erkennbaren Auslöser, doch kommt die Krankheit auch familiär gehäuft 
vor, wobei Mutationen in bisher sechs Genen als Ursache identifiziert 
werden konnten. Eine Untergruppe der autosomal-rezessiven form der 
Parkinsonkrankheit wird durch Mutation im Parkin-Gen, das für eine E3 
Ubiquitinligase kodiert, bewirkt. Es gibt mehrere Hinweise darauf, dass 
oxidativer Stress die Parkinsonkrankheit begünstigt. Weil eine Störung 
im Schwermetallhaushalt der Zelle oxidativen Stress bewirken kann, 
haben wir bei einer Parkin-Mutante der Essigfliege Drosophila 
melanogaster den Effekt einer veränderten Schwermetall-Homöostase 
getestet. Homozygote Parkin-mutante Fliegen zeigen schwere motorische 
Defekte einschliesslich Flugunfähigkeit, männliche und weibliche 
Sterilität, und stark verkürzte Lebensdauer. Wir konnten zeigen, dass eine 
Doppelmutante für Parkin und MTF-1 (metal responsive transcription 
factor, auch metal response element binding transcription factor genannt) 
nicht lebensfähig ist, d.h. “synthetische Letalität” zeigt. Die 
hauptsächlichen Zielgene von MTF-1 kodieren für Metallothioneine, 
kleine cysteinhaltige Proteine welche in der Lage sind etliche Metalle, 
z.B. Kupfer, Zink, Kadmium und Quecksilber zu binden, oder Radikale 
zu neutralisieren. Interessanterweise zeigen transgene Fliegen mit 
erhöhtem MTF-1-Spiegel eine dramatische Verlängerung der 
Lebensdauer und eine verbesserte Motorik, welche sogar zu kurzen 
Flügen befähigt. Zudem sind die Weibchen (allerdings nicht die 
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Männchen) fruchtbar. Auf zellulärer Ebene ist die Struktur der Ovarien 
und der Flugmuskeln weitgehend normalisiert. Weitere Experimente mit 
Parkin-Mutanten ergaben starke Verbesserungen im Phänotyp auf Futter 
mit BPS und BCS, zwei Chelatoren mit Präferenz für die redox-aktiven 
Metalle Eisen und/oder Kupfer. Schliesslich wurden auch noch eine 
verlängerte Lebensspanne, verbesserte Motorik und teilweise 
Wiedergewinnung der weiblichen Fertilität beobachtet, wenn Parkin-
Mutanten auf Futter mit Zink-Zusatz aufgezogen und gehalten wurden. 
Ein besonders günstiger Effekt wurde dabei mit einer hohen 
Konzentration (4 mM Zinkchlorid) beobachtet, welche bei Kontroll-
Fliegen bereits Vermeidungsreaktionen und einen verschlechterten 
Gesamtzustand bewirkten. Zink ist, im Gegensatz zu Kupfer und Eisen, 
kein redox-aktives Metall und wirkt unter den meisten Bedingungen als 
Antioxidans, was zumindest teilweise den positiven Effekt auf Parkin-
Mutanten erklären könnte. Zusammengefasst lässt sich sagen, dass unsere 
Studien eine Verbindung zwischen Parkin-Funktion und Schwermetall-
Homöostase nahelegen, welche auch für Säuger einschliesslich des 
Menschen von Bedeutung sein könnte.  
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SUMMARY 
 
Parkinson’s disease (PD) is the second most common neurodegenerative 
disease. The symptoms are tremor and rigidity and a mask-like face 
expression. At the cellular level PD is caused by progressive loss of 
neurons in a brain region termed Substantia nigra. PD in most cases is 
idiopathic, but a fraction is caused by specific dominant or recessive 
mutations in either of six genes known. Some autosomal recessive PD are 
caused by mutations in the gene for Parkin, a E3 ubiquitin ligase. Several 
lines of evidence point to oxidative stress as a major cause of PD. Since a 
distortion of cellular heavy metal homeostasis has been associated with 
increased oxidative stress, we analyzed the response of a parkin mutation 
(park25) in the vinegar fly Drosophila melanogaster to modulation of 
heavy metal homeostasis. Drosophila homozygous parkin mutants suffer 
from severe motoric defects including inability to fly, male and female 
sterility, and a very short life span. We found that a combination of a 
parkin mutation with a loss-of-function mutation of MTF-1 (metal 
responsive transcription factor, also referred to as metal response element 
binding transcription factor) is not viable, i.e., displays a “synthetic lethal 
phenotype”. The major target genes of MTF-1 are encoding 
metallothioneins, small cysteine-rich proteins with the ability to bind a 
number of metals, including copper, zinc, cadmium and mercury, and 
also to scavenge radicals. Interestingly, transgenic flies with elevated 
MTF-1 expression show a dramatic prolongation of life span and 
improvement of motoric abilities which even includes short patches of 
flight. Furthermore the females (but not the males) are fertile. At the 
cellular level, muscle and ovary morphology are largely normalized. In 
an independent set of experiments with parkin mutants, we also find a 
beneficial effect upon food supplementation with BPS and BCS, 
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chelators with a preference for the redox-active metals iron and/or 
copper. Finally, improved life span, motoric abilites and partial recovery 
of female fertility is also observed when parkin mutants are raised and 
kept on food with a supplement of zinc ions. A particularly good effect is 
seen at a food zinc concentration (4 mM) which is already showing 
avoidance reactions and adverse effects in control flies. Zinc, unlike iron 
and copper, is not redox-active and under most circumstances acts as an 
anti-oxidant, which might at least in part explain its positive effect on the 
parkin mutant flies. Taken together, our findings point to an intriguing 
interplay between Parkin function and metal homeostasis which may well 
have relevance to mammals including humans.  
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INTRODUCTION 
 
  I Parkinson’s disease 
 II MTF-1 
III zinc homeostasis 
 
I)Parkinson’s disease 
 
1.1 Clinical and pathological features of Parkinson’s Disease 
Parkinson’s disease (PD) is the most common chronic movement disorder and the 
second most common neurodegenerative disorder which was first described by James 
Parkinson in 1817. The incidence of this disease, markedly increases with age 
(Twelves et al., 2003), typically manifesting itself after the age of 50, with an 
estimation of about four million people worldwide and 1% of the population above 
the age of 65 years being inflicted (Bushnell and Martin, 1999; Chung et al., 2003). 
Clinical manifestations of PD patients include a broad range of motor abnormalities 
including rigidity, bradykinesia (slowness of voluntary movement), resting tremor and 
postural instability. The movement disorder in PD can be largely credited to the 
selective loss of dopaminergic neurons in the nigrostriatal pathway of the brain 
(Dawson, 2000; Parkinson, 2002; Spacey and Wood, 1999). There are several 
secondary symptoms, such as constipation, difficulties in swallowing, loss of bladder 
and/or bowel control, abnormalities in olfactory and visual perception, bradyphrenia 
(slow response to questions) and hypophonia (soft voice) in addition to psychosocial 
disorders, such as, anxiety and depression as well as dementia and cognitive 
impairment (Gelb et al., 1999). In order to be surely diagnosed with PD, a patient 
must have at least two or more of the primary symptoms, one of which should be 
either resting tremor or bradykinesia. A caveat is that several other diseases display 
similar symptoms defined for PD making a definitive diagnosis possible post mortem. 
The motoric impairments in PD are usually responsive to levodopa (L-DOPA), 
resulting in the improvement of these clinical symptoms (Gelb et al., 1999).  
 
Pathologically, PD is characterized by the presence of cellular inclusions called 
“Lewy bodies” and a progressive but selective loss of dopaminergic neurons in the 
substantia nigra pars compacta (SNc) which is necessary for normal motor function. 
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This selective loss of dopaminergic neurons ultimately leads to the loss of dopamine 
(DA), its metabolites, 3,4 dihydroxyphenylacetate (DOPAC) and homovanillic acid 
(HVA), the dopamine transporter (DAT) in the striatum and the SNc, and its 
biosynthetic enzyme, tyrosine hydroxylase (Zhang et al., 2000). The first PD 
symptoms develop when about 70% of the striatal dopamine  neurons and about 50% 
of the nigral dopamine neurons are lost (Dunnett and Bjorklund, 1999; Lansbury and 
Brice, 2002). Friedrich Lewy first described the pathological hallmark of PD, Lewy 
bodies in 1912 as a hyaline inclusion in the neuronal cytoplasm. Classical Lewy 
bodies are 5-25 µM fibrillar, proteinaceous cytoplasmic inclusions with a dense 
eosinophilic core surrounded by a clear halo and are usually found in the SNc and 
locus coeruleus of PD patients (Huang et al., 2004; Pollanen et al., 1993). Misfolded 
proteins can be generated due to genetic mutations (Goldberg et al., 2003) or 
oxidative modifications (Dalle-Donne et al., 2006) and accumulate in Lewy bodies, 
most likely due to a chronic imbalance in their generation and clearance. The main 
component of Lewy bodies is α-Synuclein (Goedert and Spillantini, 1998; Iwatsubo, 
2003; Spillantini et al., 1997). In some Lewy bodies, several other proteins were 
shown to be present besides α-Synuclein. These include Ubiquitin (Manetto et al., 
1988), Ubiquitin-carboxyterminal hydrolase (UCH-L1) (Lowe et al., 1990), 
Synphilin-1 (Wakabayashi et al., 2000), Tau (Ishizawa et al., 2003), Parkin-
associated-endothelin receptor-like receptor (Pael-R) (Murakami et al., 2004), Parkin 
(Schlossmacher et al., 2002), neurofilaments (Schmidt et al., 1991), Torsin A 
(Shashidharan et al., 2000) and heat shock proteins such as Hsp70 and Hsp90, which 
act as molecular chaperones (Auluck and Bonini, 2002). Misfolded proteins are prone 
to aggregate formation and have the potential to impair cellular functions (Gregersen 
et al., 2006). Lewy bodies most likely have a protective function by sequestering 
these potentially cytotoxic proteins and preventing them from damaging cellular 
organelles present in the cytoplasm. In agreement with this idea, dopamine neurons 
containing Lewy bodies have been reported to escape from degeneration in PD, 
suggesting that Lewy-body positive neurons are less vulnerable than their Lewy-body 
negative counterparts (Tompkins and Hill, 1997). 
 
Neurobiochemical implications of PD include mitochondrial complex I dysfunction, 
reduced glutathione, increased lipid peroxide and iron levels and decreased ferritin 
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concentrations which suggest that dopaminergic neurons of PD patients are under 
oxidative stress (Kosel et al., 1999; Munch et al., 1998). Furthermore, recent studies 
have implied altered proteasomal function as one of the contributing factors in the 
pathogenesis of PD (McNaught et al., 2003). 
  
Evidence suggests that both environmental and genetic factors play contributing roles 
in the etiology of the disease. Both exogenous environmental toxins and endogenous 
proteotoxins have been implicated in PD pathogenesis (Yang et al., 2003). The 
molecular mechanism(s) underlying the selective dopaminergic neuronal loss in PD 
are not clearly outlined, but accumulating evidence indicate that mitochondrial 
dysfunction, oxidative stress, impaired ubiquitin-dependent proteolysis and protein 
aggregation are involved in the pathogenesis of PD. Mutations in a number of genes 
have been found to be linked to various inherited forms (familial) PD and several of 
them are associated with the ubiquitin-proteasome protein degradation pathway. 
Although inherited forms of PD account for only about 5-15% of known PD cases (de 
Silva et al., 2000; Gasser, 2001; Mizuno et al., 2001), the symptoms and 
neuropathology are essentially identical to idiopathic PD. However, most PD cases 
are still believed to be sporadic. Hence, the hunt for the possible environmental 
contaminants or other non-genetic causes that are linked to the development of PD 
still remains an active area of research. 
 
1.2 Genetics of PD 
 
1.2.1 Parkin (PARK2) 
The gene PARK2 also known as parkin was identified by positional cloning in 
Japanese families (Kitada et al., 1998). The locus PARK2 responsible for causing 
autosomal-recessive juvenile PD (AR-JP), characterized by early-onset, slow disease 
progression and mostly absence of Lewy bodies, barring an exceptional case (Farrer 
et al., 2001; Mori et al., 1998; Takahashi et al., 1994) was mapped to chromosome 
6q25.2-27 (Matsumine, 1999).  
 
The parkin gene is one of the largest genes in the human genome (1.53 Mb), 
containing 12 exons and encoding a 465-amino acid protein of 52 kDa molecular 
weight. The parkin promoter functions as a bi-directional promoter. It regulates the 
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transcription of parkin on the one hand and a gene upstream of parkin in an antisense 
orientation, called PACRG which encodes Parkin co-regulated gene (PACRG) or 
Gene located upstream of parkin (Glup) on the other hand (West et al., 2003).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Schematic representation of the Parkin/PACRG locus.  
The chromosomal location is shown (left). 12 individual exons of parkin are marked 
(not to scale) with intron sizes indicated (middle). Protein domain structure is 
indicated (right). Adapted from Mata et al., 2004. 
 
 
PACRG is a component of Lewy bodies and forms a part of the chaperone complex 
with Hsp70 and Hsp90 and it suppresses unfolded Pael receptor-induced neuronal cell 
death (Imai et al., 2003), however, its exact function is unclear at present. This 
suggests a model of toxicity reduction of Pael-R in dopamine neurons by the joint 
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action of Parkin which degrades its substrate, Pael-R and PACRG which sequesters 
Pael-R into Lewy bodies. 
 
Structure, expression and function of Parkin 
Besides a ubiquitous expression in the brain, Parkin is found in several cellular 
compartments, including the cytosol, trans-Golgi network, synaptic membrane 
compartment, postsynaptic densities, lipid rafts, cytoplasmic vesicles, endoplasmic 
reticulum, outer nuclear and outer mitochondrial membranes (Fallon et al., 2002; 
Kubo et al., 2001; Shimura et al., 1999; Stichel et al., 2000). Functional Parkin protein 
has been suggested to be a requirement for Lewy body formation as it has been found 
in Lewy bodies of autosomal dominant PD patients (Schlossmacher et al., 2002; 
Shimura et al., 2001). However, several other studies failed to detect Parkin in Lewy 
bodies or Lewy neurites by Parkin antibodies (Pawlyk et al., 2003).  
 
Parkin has a ubiquitin-like (UBL) domain at its N-terminus and two RING (Really 
Interesting New Gene) fingers, a type of zinc finger flanking the IBR (In-Between-
RING fingers) domain at its C-terminus. The UBL domain binds to the Rpn10 subunit 
of the 26S proteasome (Sakata et al., 2003) and is also involved in substrate binding 
(Shimura et al., 2000). The segment present in between the UBL and RING1-IBR-
RING2 domains shows no clear similarity to known proteins and was accordingly 
termed the unique parkin domain (UPD) (Kahle et al., 2000a). The PDZ-binding 
motif at the C-terminus of Parkin interacts with the calcium/calmodulin-dependent 
serine protein kinase (CASK) (Fallon et al., 2002) which co-localizes with Parkin at 
postsynaptic terminals and in lipid rafts in rat brain in vivo as well as in synapses in 
cultured cortical neurons. There is high evolutionary conservation in Parkin, with 
orthologs in Drosophila melanogaster, Caenorhabditis elegans, mouse, rat and other 
species (Bae et al., 2003; Culetto and Sattelle, 2000). Drosophila Parkin shows 42% 
amino-acid sequence identity to human Parkin (Bae et al., 2003). 
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Figure 2: Alignment of the amino acid sequence of D. melanogaster parkin with 
human, mouse and rat. The conserved domains are in bold and ubiquitin-like 
domain is in red. RING domains are shown in green and IBR domain is indicated in 
blue. According to Bae et al., 2003. 
 
 
Parkin functions as an E3 ubiquitin ligase 
A number of RING finger proteins function as E3 ubiquitin protein ligase which play 
an important part in the ubiquitin proteasome system (UPS). The E3 ligases are 
responsible for the covalent attachment of Ubiquitin to proteins that are targeted for 
degradation by the proteasome (Joazeiro and Weissman, 2000). The UPS is involved 
in the temporal degradation of short-lived proteins which have important roles in cell-
cycle, signal transduction and metabolism. Additionally, the UPS ensures protein 
quality control, it removes the misfolded or aggregated proteins by recruiting the E3 
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ubiquitin ligase, which further links the protein folding (chaperone) and degradation 
(proteasome) machinery of the cell. 
 
Extensive molecular, genetic and functional analyses have shown that Parkin is an E3 
ubiquitin protein ligase which is involved in protein turnover via the UPS (Shimura et 
al., 2000). Mutants for the Parkin RING domain lose their E3 ligase activity and the 
ability to bind to E2 ubiquitin conjugating enzymes, such as UbcH7 (Shimura et al., 
2000). This indicates that the RING domain is required for recruitment of E2 enzymes 
into the Parkin complex. α-Sp22, a 22-kDa glycosylated form of alpha-synuclein 
notwithstanding, all Parkin substrates bind to Parkin via its RING finger domain 
(Shimura et al., 2001). Hence, mutations in the RING-IBR-RING domain can affect 
both substrate recognition as well as E2 binding, either of which results in partial or 
total loss of substrate degradation ability. Parkin can ubiquitinylate substrates by 
joining Ubiquitin moieties either via the classical lysine 48 (K48) (Pickart, 2001) or 
via the unclassical lysine 63 (K63), resulting in totally different outcomes, as 
displayed by the Parkin-binding protein Synphilin-1 which is an α-Synuclein-
interacting protein (Lim et al., 2005). While K48-linked ubiquitination of Synphilin-1 
promotes its proteasomal degradation, K63-linked ubiquitination by Parkin may be 
involved in the formation of Lewy body inclusions formed by the coexpression of α-
Synuclein and Synphilin-1 associated with PD (Lim, et al. 2005) (Chung et al., 2001). 
The relative expression levels between Parkin and Synphilin-1 determine the 
Synphilin-1 degradation kinetics. Appreciable degradation of Synphilin-1 by Parkin 
occurs only at an unusually high Parkin to Synphilin-1 expression ratio or when the 
system is primed for lysine-48 (K48) ubiquitination. In contrast, parkin ubiquitinates 
Synphilin-1 via K63-linked ubiquitin chains when Synphilin-1 and Parkin are 
coexpressed at equivalent levels (Lim et al., 2005). This suggests that Parkin may act 
as a dual-function ubiquitin protein E3 ligase capable of mediating both proteasomal-
linked (K48) and proteasomal-independent (K63) ubiquitination under different 
cellular conditions. 
 
Mutations in parkin cause autosomal-recessive juvenile PD (AR-JP) 
The most frequent form of familial PD is Parkinsonism due to parkin mutations. Half 
of the inherited PD cases are estimated to be caused by mutations in parkin (Lohmann 
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et al., 2003). (Huynh et al., 2003). Homozygous mutations usually result in the loss of 
Parkin’s E3 ligase activity along with altered Parkin levels (Finney et al., 2003). 
Parkin mutations include exonic deletions, insertions and several missense mutations, 
with the hotspots for point mutations in the two RING finger motifs, the IBR as well 
as the UBL domain (von Coelln et al., 2004a). In addition to homozygous mutations, 
compound heterozygous mutations have been identified in patients that displayed PD 
symptoms clinically indistinguishable from idiopathic PD (Klein et al., 2000). 
 
Substrates of Parkin 
 
(A) Substrates forming components of Lewy bodies 
A.1 α-Synuclein: Parkin interacts with a rare O-linked glycosylated form of α-
Synuclein (α-Sp22) in Lewy bodies that were extracted from post-mortem brain 
tissue of AR-JP patients (Shimura et al., 2001), while mutant parkin fails to 
ubiquitinylate α-Sp22 in vitro (Chung et al., 2001). Parkin protects against α-
Synuclein toxicity in vitro (Petrucelli et al., 2002) and prevents α-Synuclein induced 
dopaminergic neuron death in Drosophila and rat models of PD (Lo Bianco et al., 
2004; Yang et al., 2003).  
 
A.2 Synphilin-1 
Synphilin-1 is a major component of Lewy bodies found in PD patients (Wakabayashi 
et al., 2000). Parkin ubiquitinates Synphilin-1, an α-Synuclein-interacting protein 
(Chung et al., 2001). Upon binding to synaptic vesicles Synphilin-1 possibly regulates 
the synaptic functions of α-Synuclein, by anchoring it to vesicle membranes (Ribeiro 
et al., 2002). Functional Parkin is essential for the formation of Lewy body inclusions. 
This is consistent with the absence of Lewy bodies in patients with AR-JP. 
 
A.3 Pael-Receptor (Pael-R) 
The Parkin-associated endothelin receptor-like receptor (Pael-R) is a putative G-
protein-coupled multipass endoplasmic reticulum transmembrane protein which is 
abundantly expressed in dopamine neurons of the substantia nigra (Imai et al., 2001) 
and is found in the Lewy bodies of PD patients (Murakami et al., 2004). The folding 
of Pael-R is assisted by the 70-kDa heat-shock protein Hsp70. Overexpressed Pael-R 
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is insoluble and it triggers the so-called unfolded protein response which leads to ER 
stress. Insoluble Pael-R is ubiquitinated by Parkin with the help of ER-resident 
ubiquitin-conjugating enzymes (Ubc6 and Ubc7) and sent for proteasomal 
degradation before its accumulation (Imai et al., 2001).  
 
A.4 p38 subunit of the aminoacyl-tRNA synthetase complex 
The degradation of p38, a major structural component of the aminoacyl- tRNA 
synthetase complex is carried out by Parkin mediated ubiquitination (Corti et al., 
2003). Overexpression of p38 induces cell death. p38 is found in Lewy bodies of 
patients with idiopathic PD. 
 
A.5 Synaptotagmin XI 
Synaptotagmin XI is localized to the core of Lewy bodies and its interaction with 
Parkin results in its ubiquitination and degradation (Huynh et al., 2003). The 
synaptotagmin family is crucial for vesicle formation and docking. The interaction 
with a member of the synaptotagmin family suggests an involvement of Parkin in the 
regulation of proteins involved in controlling neurotransmitter trafficking at the 
presynaptic terminal. 
 
(B) Substrates regulating neurotransmitter secretion and uptake 
B.1 Dopamine transporter (DAT) 
DAT belongs to the catecholamine transporter protein family and is localized to the 
plasma membrane of dopamine neurons (Hersch et al., 1997). It regulates the uptake 
of dopamine from the synaptic cleft (Torres et al., 2003). Lack of glycosylation 
promotes the misfolding and aggregation of DAT which further oligomerizes with 
correctly folded DAT, affecting the targeting of normal DAT to the plasma membrane 
(Sorkina et al., 2003). Parkin significantly enhances the ubiquitination and subsequent 
degradation of misfolded DAT (Jiang et al., 2004). Results showing a significantly 
reduced DAT in the striatum of parkin knockout mice are in perfect agreement with 
the required role of Parkin in DAT targeting (Itier et al., 2003). 
 
(C) Polyglutamine proteins 
Polyglutamine proteins are aggregation-prone cytosolic proteins. Cytosolic protein-
misfolding stress results in an upregulation of Hsp70 which further recruits Parkin 
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through its interaction with the RING-IBR-RING domain (Tsai 2003).  The 
polyglutamine protein is then ubiquitinated and targeted for proteasomal degradation. 
This process might be facilitated by the direct binding of the UBL domain of Parkin 
to the regulatory 19S proteasome (Sakata et al., 2003).  
 
(D) Substrates involved in cell cycle regulation and cytoskeleton structure 
D.1 Septin family of proteins - CDCrel-1 and CDCrel-2a 
Cell-division control-related protein-1 (CDCrel-1), also known as Sept5, belongs to 
the a family of GTPase called septin. It is predominantly expressed in the nervous 
system and is ubiquitinated and degraded by Parkin (Beites et al., 1999; Zhang et al., 
2000). CDCrel-1 accumulates in the brains of AR-JP patients (Choi et al., 2003). 
CDCrel-2a, another member of the septin family having strong homology to CDCrel-
1, coimmunoprecipitates with Parkin from human substantia nigra lysates and is also 
ubiquitinated by Parkin in vitro (Choi et al., 2003). (Beites et al., 1999). Septins are 
evolutionary conserved proteins with essential functions in cytokinesis, and 
throughout the cell cycle. These small proteins likely with GTPase activity seem to 
function in membrane transport and exocytosis (Field and Kellogg, 1999).  
 
D.2 Cyclin E 
A number of RING proteins including Skp1, Cullin and F-box (SCF) complexes have 
been shown to function within multiprotein ubiquitin ligase complexes (Joazeiro and 
Weissman, 2000; Patton et al., 1998). Parkin is part of a SCF complex containing 
hSel-1 and Cullin-1 (Staropoli et al., 2003). This complex auto-ubiquitinates Parkin 
and also ubiquitinates Cyclin E via HSel-1 (Staropoli et al., 2003). Cyclin E is 
involved in kainite-induced excitotoxicity and primary neuronal apoptosis. Parkin 
knockdown by RNA interference results in the accumulation of Cyclin E in the 
primary cerebellar granule cells, while Parkin overexpression inhibits kainite-induced 
Cyclin E apoptosis (Staropoli et al., 2003).  
 
D.3 α- and β-Tubulin 
It was shown that Microtubule-associated protein 1A (MAP1A) binds Parkin in a 
temperature-sensitive manner with a higher coimmunoprecipitation at 37oC than at 
4oC (Feng and Lin, 2001). This suggested that Parkin may be binding to MAP1A via 
microtubules, as polymerization of microtubules is known to be more efficient at 
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37oC. Parkin was later identified as a tubulin-binding protein and an E3 ligase for α- 
and β-Tubulins (Ren et al., 2003). Interestingly, Parkin overexpression stabilized 
microtubules against colchicine-induced depolymerization (Yang et al., 2005). 
 
Drosophila parkin null mutants  
Animal models of PD have facilitated the study of the mechanisms and processes 
involved in the pathogenesis of the disease. Till date, none of the animal models have 
been able to recapitulate all the hallmark pathologies and symptoms (Auluck and 
Bonini, 2002; Hamamichi et al., 2008). These models are generated via knockdown or 
mutagenesis of genes implicated in PD or by treatment with environmental toxins like 
1-methyl, 4-phenyl-1,2,3,6-tetrahydropyridine and paraquat (Dauer and Przedborski, 
2003). In our study, we use a Drosophila model of PD. To explore the biological role 
of parkin, a series of mutations have been generated in the Drosophila ortholog of 
parkin, including deletion, nonsense and missense mutations. Two lines of parkin null 
mutant flies were generated by insertional mutagenesis with activated EP element 
transposons by two independent groups (Greene et al., 2003; Pesah et al., 2004). In 
one line (used in our study), parkin-deficient males are sterile but the females are 
reported to be fertile (sterile in our hands) (Greene et al., 2003). Male sterility was 
further studied and was found to be derived from a spermatid individualization defect 
at a late stage of spermatogenesis, which may be a result of defective Nebenkern 
formation and/or function (Greene et al., 2003). The Nebenkern is a specialized 
mitochondrial derivative in the mature sperm. Ultrastructural analysis of parkin 
mutant males revealed severe disruption of the Nebenkern integrity. In contrast to this 
study, the other group reported both male and female sterility with homozygous 
parkin deletion (Pesah et al., 2004). They also reported an increased sensitization to 
oxidative stress and a 30% lower mass of parkin mutants in comparison to wild type 
controls. A reduced cell size and cell number accounted for this mass reduction. 
 
Parkin-deficient flies show a reduced longevity and a partially penetrant downturned 
wing phenotype (Greene et al., 2003). Locomotor activity assays revealed severe 
defects in flight and climbing activity. These locomotor defects derive from apoptotic 
cell death of mitochondria and muscle subsets. Histological analysis of the major 
flight muscles from parkin mutants showed an extensive disruption of muscle 
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integrity, which was consistent with their inability to fly. Ultrastructural analysis of 
the flight muscles demonstrated a disintegration of the mitochondria with fragmented 
cristae which indicate that Parkin might regulate mitochondrial integrity. Similar to 
parkin knockout mice (Goldberg et al., 2003; Itier et al., 2003; Palacino et al., 2004; 
Perez and Palmiter, 2005; Von Coelln et al., 2004b), no significant dopamine neuron 
loss was observed in the mutant flies (Greene et al., 2005; Greene et al., 2003; Pesah 
et al., 2004), notwithstanding the observation of a 20% loss in one study involving 
only one subset of the dopamine neuron clusters in the fly brain (Whitworth et al., 
2005). Transcriptional analysis indicated that genes involved in the innate immune 
response and oxidative stress components are upregulated in the parkin mutant 
animals (Greene 2005). A genetic screen for mutations in genes that either enhance or 
suppress the lethality of Drosophila parkin mutants revealed that loss-of-function 
mutations in oxidative stress components, such as glutathione S-transferase S1 
enhance the Parkin mutant phenotype (Greene et al., 2005). The lifespan of the 
mutant flies is further reduced when they are grown on environmental toxins like 
rotenone or paraquat, which generates toxic free radicals in vivo (Pesah et al., 2004). 
 
1.2.2 α-Synuclein (PARK 1) 
α-Synuclein (also known as NACP, Synuclein-1 or Synelfin) was first discovered in 
the Torpedo (electric eel) electrical organ as a vesicle-associated component (Clayton 
and George, 1999) and was identified as the precursor protein of the non-amyloid β 
component of the senile plaques of Alzheimer’s disease (Iwai, 2000). α-Synuclein has 
140 amino acids and consists of three domains, including an amino-terminal 
amphipathic lipid binding α-helix, a hydrophobic β-amyloid binding domain that 
encodes the non-Aβ component (NAC) and an acidic carboxy-terminal tail.  
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Figure 3: Schematic representation of α-Synuclein. The N-terminal region consists 
of 7 imperfectly conserved KTKEGV repeats. This motif has unknown physiological 
significance. The NAC domain is extremely hydrophobic and the C-terminal region is 
negatively charged. The three known missense mutations are localized to the N-
terminal repeat region. 
 
 
Either oxidative stress or mutations of α-synuclein may lead to the formation of 
highly toxic protein aggregates or fibrils, ultimately resulting in neuronal cell death. 
Missense mutations in the α-synuclein gene have been shown to be a cause of rare 
forms of autosomal dominant familial PD. One of the first identified genetic causes of 
PD is the missense mutation A53T in the α-synuclein gene in a large Italian and 
several smaller Greek kindreds. (Polymeropoulos et al., 1996; Polymeropoulos et al., 
1997). Thereafter, two other missense mutations were identified; A30P and E46K 
(Kruger et al., 1998; Zarranz et al., 2004). Additionally, a triplication of the wild type 
α-synuclein gene resulting in α-Synuclein overexpression is also associated with 
familial PD (Singleton et al., 2003), indicating that both the composition and dosage 
of α-Synuclein appear to play roles in the development of PD. Oxidative stress has 
been shown to promote the aggregation of α-Synuclein in several studies (Hashimoto, 
M. 1999, Neuroreport 10: 717-721. Oxidative stress induces amyloid-like aggregate 
formation of NACP/alpha-synuclein in vitro) (Ostrerova-Golts, N. 2000. J. Neurosci 
20: 6048-54) (Paxinou, E. 2001, J.Neurosci 21: 8053-61) (Sherer, TB 2002, J. 
Neurosci 22: 7006-15). Modifications in the primary structure of the α-Synuclein 
protein may enhance its oligomerization and subsequent fibril formation (Conway et 
al., 1998). 
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Localization and putative functions of α-Synuclein 
The location of α-Synuclein is predominantly in the brain and in presynaptic 
terminals but its normal physiological functions is largely unknown (Clayton and 
George, 1999; Jakes et al., 1994; Kahle et al., 2000b), though it appears to be 
involved in the biosynthesis of dopamine, synaptic vesicle recycling (Baptista et al., 
2003; Perez et al., 2002) and synaptic plasticity (Clayton 1999). α-Synuclein 
associates with lipid membranes (Jo et al., 2000) and co-localizes with Synaptophysin 
and SNAP-25, which promote vesicle docking and fusion (Irizarry et al., 1996; 
Withers et al., 1997). In vitro studies revealed that α-Synuclein can bind these 
structures through its N-terminal repeat domain, thereby causing dramatic alterations 
in its secondary structure (Davidson et al., 1998; Jensen et al., 1998). This led to the 
hypothesis that α-Synuclein has an important function in vesicular transmitter release 
and synaptic plasticity (Clayton and George, 1998). Different animal models have 
been created to investigate how α-Synuclein causes PD. α-Synuclein knockout mice 
display neurodegeneration along with altered compartmentalization of presynaptic 
dopamine and decreased capacity of dopamine storage pool (Yavich et al., 2004). In 
addition the reduction in the quantal release of dopamine that usually occurs post 
repetitive stimulation of the same neurons was inhibited in mice lacking α-Synuclein 
while the dopamine-dependent response to amphetamine was increased (Abeliovich et 
al., 2000). These results are indicative of the role of α-Synuclein in the regulation of 
dopamine homeostasis. However, the involvement of α-Synuclein is not only 
restricted to dopamine neurons, as its loss has been shown to alter synaptic 
transmission at glutamatergic synapses as well (Martin et al., 2004). α-Synuclein 
transgenic flies display a selective dopaminergic neuronal loss and the presence of 
Lewy body-like inclusions in the neurons (Feany and Bender, 2000). Finally, several 
studies point towards α-Synuclein’s role as a molecular chaperone owing to its 40% 
homology with the cytoplasmic chaperone 14-3-3 (Kim et al., 2000; Ostrerova et al., 
1999). 
 
α-Synuclein aggregation and toxicity 
α-Synuclein has a high propensity to aggregate owing to its hydrophobic non-
amyloid-β domain. α-Synuclein is transformed from its normal, soluble form to a 
disease-causing fibrillar state in many neurodegenerative disorders, which are 
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collectively referred to as α-synucleinopathies (Galvin et al., 2001; Goedert, 1999; 
Spillantini and Goedert, 2000). While the C-terminal of α-Synuclein is a key 
regulator of its aggregation in vivo (Li et al., 2005), the internal hydrophobic NAC 
region is capable of fibril formation in vitro (Han et al., 1995). The fibrils formed are 
similar to those observed in Lewy bodies, particularly in the A53T mutation (Conway 
et al., 1998). The potentially neurotoxic protofibrils formed may damage vesicular 
membranes by forming pore-like channels (Lashuel et al., 2002; Volles and Lansbury, 
2002), similar to some bacterial toxins (Ding et al., 2002; Volles et al., 2001) and 
permeabilize the membranes of synaptic vesicles and other organelles, resulting in 
leakage of calcium and dopamine which are known to be cytotoxic at high levels 
(Caughey and Lansbury, 2003). This provided a mechanism of how protein 
fibrilization can cause cell death. Interestingly, the dopamine-α-Synuclein adducts 
stabilize the protofibrils (Conway et al., 2001). A pathological modification involving 
the phosphorylation of Ser129 in α-Synuclein was shown to promote aggregation 
besides forming a major component of Lewy bodies (Anderson et al., 2006; Smith et 
al., 2005). The G-protein-coupled receptor kinase 5 has been recently shown to be 
responsible for this phosphorylation (Arawaka et al., 2006). α-Synuclein has been 
reported to directly bind the human dopamine transporter in cotransfected cells (Lee 
et al., 2001) which may result in elevated dopamine levels and subsequent neuronal 
death as dopamine may participate in oxidative stress generating reactions, since both 
dopamine auto-oxidation and its metabolism produce reactive oxygen species (ROS). 
In addition, α-Synuclein inhibits of Tyrosine hydroxylase (Perez et al., 2002). Several 
studies link mutated α-Synuclein to an increased sensitivity of cells to proteasomal 
inhibitors by a decreased protesomal function (Petrucelli et al., 2002; Stefanis et al., 
2001; Tanaka et al., 2001). Synphilin-1 binds to α-Synuclein in vivo and this 
association promotes the formation of intracellular inclusions (Engelender et al., 
1999). In addition, it is suggested that Synphilin-1 regulates the synaptic functions of 
α-Synuclein, possibly by anchoring α-Synuclein to vesicular membranes (Ribeiro et 
al., 2002).  
 
α-synuclein was the first gene shown to be associated with a heritable form of PD and 
was also the first of all PD-related genes to be studied in a Drosophila model of PD. 
Loss of dopamine neurons was observed in a transgenic Drosophila model of PD 
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caused by mutant α-Synuclein (Feany and Bender, 2000) in contrast to observations 
with several lines of α-synuclein transgenic mice which failed to develop dopamine 
neuron loss (Fernagut and Chesselet, 2004). On the other hand, rats overexpressing 
mutant synuclein, A30P (Klein et al., 2002; Lo Bianco et al., 2002) or A53T (Kirik et 
al., 2003), developed a progressive loss of dopaminergic neurons. 
 
1.2.3 PINK1 (PARK6) 
The ubiquitously expressed PINK1 transcript encodes a 581 amino acids protein 
(Unoki and Nakamura, 2001) with a mitochondrial targeting motif at the N-terminal 
and a highly conserved protein kinase domain (156-509 amino acids) (Rohe et al., 
2004; Valente et al., 2004), which is homologous to the serine/threonine kinases of 
the calcium/calmodulin family. Known mutations in PTEN-induced kinase 1 
(PINK1), associated with the PARK6 locus which result in early-onset autosomal-
recessive PD include a W437Stop, nonsense and a G309D, missense mutation within 
the PINK1 kinase domain (Valente et al., 2004) and an insertion outside the kinase 
domain causing a frameshift and truncation at the C-terminus of PINK1 (Rohe et al., 
2004). The mutants have an increased susceptibility to cellular stress. The wild type 
PINK 1 may prevent PD by protecting neurons from stress-induced mitochondrial 
dysfunction through phosphorylation of mitochondrial proteins (Valente et al., 2004). 
Loss-of-function mutations in the Drosophila PINK1 ortholog results in 
morphological abnormalities of the mitochondria and apoptosis in testes ad flight 
muscles with dopaminergic neuronal loss in some cases (Clark et al., 2006; Park et 
al., 2006; Yang et al., 2006). Parkin overexpression rescues the PINK1 phenotype but 
the vice versa is not true. This indicates a functional relationship between the two 
genes implicated in PD, suggesting that PINK1 functions upstream of parkin (Kitada 
et al., 2007). 
  
1.2.4 Ubiquitin C-terminal hydroxylase L1 (PARK5) 
Ubiquitin C-terminal hydroxylase L1 (UCH-L1) is a thiol protease that produces 
ubiquitin possibly by cleaving ubiquitin polymers or by releasing ubiquitin from 
cellular adducts with glutathione or amine (Larsen et al., 1998; Larsen et al., 1996). 
An autosomal dominant missense mutation (I93M) in the gene encoding UCH-L1 was 
first identified in two siblings having a strong family history of PD (Leroy et al., 
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1998). UCH-L1 is an abundant neuronal enzyme that makes up 1-2% of the total 
brain protein, with an unknown function (Wilkinson et al., 1989). Quite interestingly, 
UCH-L1 has two enzymatic activities with opposite effects, both of which may play a 
role in proteasomal protein degradation: a beneficial hydrolase activity and a partly 
pathogenic dimerization-dependent ligase activity which causes the accumulation of 
α-synuclein in cultured cells. The I93M mutation decreases the in vitro hydrolytic 
activity of UCH-L1 (Liu et al., 2002). UCH-L1 is also present in Lewy bodies of 
sporadic PD (Lowe et al., 1990) and I93M mutant was shown to be able to produce 
inclusions (Ardley et al., 2004). A S18Y polymorphism was also discovered in the 
UCH-L1 protein and subsequently found to be linked to a decreased susceptibility to 
PD (Levecque et al., 2001; Maraganore et al., 1999; Satoh and Kuroda, 2001), 
possibly because it reduces the ligase activity of UCH-L1 while promoting its 
hydrolase activity (Liu et al., 2002). 
 
 
1.2.5 DJ-1 (PARK7) 
PARK7, which encodes a protein DJ-1 is yet another locus linked to early-onset 
recessive PD. Various mutations identified in affected individuals include exonic 
deletions, truncations and point mutations (L166P and M26I) (Abou-Sleiman et al., 
2003; Bonifati et al., 2003; Hague et al., 2003; Hedrich et al., 2004). DJ-1 was 
identified as a protein that transforms mouse NIH3T3 cells in cooperation with 
activated ras (Nagakubo et al., 1997). Apart from playing a direct role in dopamine 
neuron physiology (Goldberg et al., 2005), DJ-1 is a component of a cAMP-
responsive multiprotein complex that stabilizes (Hod et al., 1999), and it also 
functions as a positive regulator of the androgen receptor, antagonizing the function 
of negative regulators, such as DJ-1-binding protein. The human DJ-1 gene, which is 
comprised of eight exons, is mapped to 1p36.2–36.3, where many chromosome 
aberrations in cancer have been reported (Taira et al., 2001). DJ-1 was found to be 
more strongly expressed in the testis than other tissues and also in sperm. 
 
DJ-1 plays the role of a redox-sensitive molecular chaperone in vitro and in cells, 
granting protection against ROS-generated toxicity by getting induced in an oxidative 
environment and inhibiting the aggregate formation of α-Synuclein (Schapira, 2008; 
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Shendelman et al., 2004). Also, overexpression of DJ-1 reduces, while DJ-1 
knockdown by RNA interference enhances, the susceptibility of cells to oxidative 
stress (Taira et al., 2004). DJ-1 dimerization is essential for its function and the L166P 
mutation destabilizes DJ-1 by preventing dimer formation (Macedo et al., 2003; 
Moore et al., 2003), abolishing DJ-1 chaperone activity (Shendelman et al., 2004). 
Different studies in DJ-1-null mice have shown that DJ-1 protects against neuronal 
oxidative stress and that its loss may lead to PD by conferring hypersensitivity to 
dopaminergic insults (Goldberg et al., 2005; Kim et al., 2005). The Drosophila 
genome encodes two orthologs of the human DJ-1 gene, DJ-1a and DJ-1b. while DJ-
1b is expressed ubiquitously, DJ-1a is predominant in the testes (Menzies et al., 2005; 
Meulener et al., 2005; Park et al., 2005). 
  
1.2.6 Leucine-rich repeat kinase 2 (PARK8) 
Leucine-rich repeat kinase 2 also known as LRRK2 or Dardarin is a large protein  and 
a member of the leucine-rich repeat kinase family which in humans is encoded by the 
LRRK2 (PARK8) gene. Dominant mutations of LRRK2 are the most common cause 
of inherited PD. Several missense mutations and one putative splice site mutation in 
the PARK8 gene are linked to the development of PD (Paisan-Ruiz et al., 2004; 
Zimprich et al., 2004). The pathological markers of the disease vary significantly 
(Brice, 2005; Wszolek et al., 2004; Zimprich et al., 2004). LRRK 2 is present largely 
in the cytoplasm but also associates with the mitochondrial outer membrane. It is 
expressed weakly throughout the brain, with slightly elevated levels in the putamen 
and the substantia nigra regions. The protein consists of 2527 amino acids and is 
encoded by 51 exons, encoding multiple conserved domains with an ankyrin repeat 
region, a leucine-rich repeat (LRR) domain, a kinase domain, a DFG-like motif, a 
RAS domain, a GTPase domain, an MLK-like domain, and a WD40 domain. (Paisan-
Ruiz et al., 2004; Shen, 2004). LRRK2 is known to interact with the RING2 domain 
of Parkin and is hypothesized to be responsible for the phosphorylation of α-
Synuclein and Tau (Shen, 2004). 
 
1.3 Mechanisms of cell death in PD 
Although about 95% cases of PD seem to be sporadic, inherited cases have resulted in 
discovery of PD-linked genes. The genes encoding α-Synuclein, Parkin, DJ-1, 
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PINK1, UCH-L1 and LRRK2 are known to carry mutations that cause PD. Several 
homozygous and compound heterozygote mutations may result in loss of protein 
function, altered protein stability and/or localization or aggregation of accumulated 
proteins. Key mechanisms contributing to the pathogenesis of PD include 
mitochondrial impairment, oxidative stress, protein mishandling and altered dopamine 
homeostasis.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4: Genetics and molecular mechanisms of PD. Black arrows indicate 
putative primary causes of PD; dashed arrows indicate effects that are secondary. 
Blue arrows indicate mechanisms of PD that are secondary to primary causes. 
mtDNA, mitochondrial DNA. According to Greenamyre and Hastings, 2004. 
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1.3.1 Oxidative stress and mitochondrial dysfunction 
Post mortem studies have repeatedly implicated oxidative stress in PD pathogenesis 
(Valente et al., 2004). Gene knockout of parkin mouse and flies show increased 
oxidative stress and mitochondrial dysfunction (Palacino et al., 2004; Pesah et al., 
2004). Reactive oxygen species (ROS) can lead to functional alterations in 
biomolecules like proteins, lipids and DNA. Immunocytochemical analyses revealed 
an increased level of oxidized RNA and DNA in nigral neurons of PD patients (Alam 
et al., 1997; Zhang et al., 1999). Leading candidates for generation of oxidative stress 
include dopamine metabolism, mitochondrial dysfunction, increased free iron levels, 
impaired free radical defense and environmental chemicals (Foley and Riederer, 
2000). ATP production in the mitochondria is regulated by respiratory chain 
complexes that are involved in the transfer of electrons to oxygen, resulting in the 
generation of free ROS. While cells tolerate normal levels of ROS, its overproduction 
combined with insufficient antioxidant defense mechanisms can induce mitochondrial 
dysfunction, which in turn may enhance the production of more deleterious ROS, 
further worsening the mitochondrial disturbed state, thus creating a vicious cycle 
(Tritschler et al., 1994). Nigrostriatal dopaminergic neurons might be particularly 
exposed to oxidative stress even under physiological conditions, probably due to 
redox cycling of catechols, resulting in the generation of detrimental ROS. Dopamine 
(DA) readily oxidizes and reacts with proteins, nucleic acids and lipids forming 
neurotoxic derivatives, including 6-hydroxydopamine, DA-quinones, superoxide 
radicals and hydrogen peroxide (Lotharius and Brundin, 2002; Olanow and Tatton, 
1999) and its interaction with intracellular iron results in formation of toxic oxygen 
radicals (Sulzer and Zecca, 2000). Additionally, DA turnover pathway involving the 
enzymatic deamination of dopamine by monoamine oxidase generates hydrogen 
peroxide along with the non-toxic dopamine metabolites, 3,4-dihydroxyphenylacetic 
acid and homovanillic acid (Graham, 1978). To escape from cytosolic DA stress, DA 
neurons have evolved several defense mechanisms which include feedback inhibition 
of tyrosine hydroxylase, metabolism by monoamine oxidase, sequestration of DA in 
synaptic vesicles as well as reduction of DA quinone by glutathione (Nakamura et al., 
2001). The quantification of the reaction products of ROS in post-mortem PD brain 
tissue serves as an indirect index of oxidative stress induced cell damage (Foley and 
Riederer, 2000). 
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1.3.2 Endoplasmic reticulum stress 
The endoplasmic reticulum (ER) caters to multiple cellular functions. Accumulation 
of misfolded proteins within the ER disturbs its normal functions, induces a highly 
specific and evolutionarily conserved unfolded protein response (UPR) and is the 
major cause of ER stress (Kaufman, 1999). ER stress is aimed initially at 
compensating for damage but can eventually trigger cell death if ER dysfunction is 
severe or prolonged. The UPR upregulates ER chaperone and folding catalysts and 
prevents further protein aggregation by attenuating protein synthesis leading to the 
activation of the ER-associated protein degradation (ERAD) for eliminating the 
harmful aggregates (Szegezdi et al., 2003). The mechanisms by which ER stress leads 
to cell death remain enigmatic, however, several mechanisms including direct 
activation of proteases, kinases, transcription factors, and Bcl-2–family proteins and 
their modulators have been implicated. ER stress has been demonstrated to produce 
mitochondrial dysfunction by interfering with the expression and assembly of the 
cytochrome c oxidase (Hori et al., 2002). Also, the steady state levels of nuclear-
encoded cytochrome c oxidase were reduced and the mitochondria-encoded subunit 
was rapidly degraded (Hori et al., 2002). UPR causes the ER-resident kinases to 
induce genes encoding ER chaperones and nuclear transcription factors that 
ultimately result in either ER stress reduction, achieved by phosphorylation of the 
eukaryotic initiation factor-2α (eIF2α) resulting in the attenuation of protein synthesis 
(Harding et al., 1999) or cell death if the damage is beyond repair (Mori, 2000). 
 
In a cell culture model of PD, ER stress was inferred from the identification of 
phosphorylated protein kinase R-like ER kinase (PERK) and Inositol-requiring-1 
(IRE1) in rat neuronal PC12 cells upon 6-hydroxydopamine exposure, which was 
taken up by the dopamine transporters and resulted in selective dopamine neuron 
death (Ryu et al., 2002). PERK (PKR-like ER kinase) is a serine-threonine protein 
kinase, the catalytic domain of which shares substantial homology to other kinases of 
the eukaryotic initiation factor 2 (eIF2) family (Harding et al., 1999; Shi et al., 1998). 
UPR was evoked by activated PERK and IRE1 (Ryu et al., 2002). Familial mutations 
in the ER-associated E3 ubiquitin ligase Parkin have also been associated with ER 
stress–induced cell death and are found in patients with familial PD (Dawson and 
Dawson, 2003; Takahashi et al., 2003). Importantly, Parkin expression is induced by 
ER stress, suggesting a role for it in adaptation to ER stress. Knockdown of parkin in 
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cell culture resulted in accumulation of its substrate Pael-R, which caused ER stress 
and cell death (Imai et al., 2001). These studies indicate that ER stress may be another 
mechanism underlying PD pathogenesis. 
 
II) Metal-responsive transcription factor-1 (MTF-1) 
 
MTF-1 (also metal-regulatory transcription factor-1), a zinc-finger transcription 
factor, is evolutionarily conserved from insects to mammals and activates cellular 
defense mechanisms in response to metals like zinc, copper and cadmium (Lichtlen 
and Schaffner, 2001; Westin and Schaffner, 1988). Its DNA binding domain consists 
of six C2H2 zinc fingers (Dalton et al., 1997; Radtke et al., 1993) and thus zinc is 
essential for the binding of MTF-1 to DNA. The DNA-binding motif is termed metal 
response element (MRE) and has a core consensus sequence of TGCRCNC (Stuart et 
al., 1984; Stuart et al., 1985). Copper and cadmium regulate MTF-1 indirectly by 
displacing zinc from zinc-loaded metallothioneins (MTs) or other zinc-binding 
proteins in vitro (Bittel et al., 1998; Zhang et al., 2003). However, in vivo, MTF-1 is 
subject to more complex regulation that includes phosphorylation and nuclear 
translocation (Saydam et al., 2002; Saydam et al., 2001). In quiescent cells, MTF-1 is 
predominantly cytoplasmic, but is translocated to the nucleus upon metal load or other 
stress conditions. In the nucleus, MTF-1 binds to the MREs and activates its target 
genes including metallothioneins, zinc transporters and placenta growth factor 
(Cramer et al., 2005; Langmade et al., 2000). 
 
The MTF-1 regulatory protein has been characterized in human (Brugnera et al., 
1994), mouse (Radtke et al., 1993), pufferfish (Auf der Maur et al., 1999), Drosophila 
(Zhang et al., 2001), zebrafish (Chen et al., 2002), carp (Ferencz and Hermesz, 2008) 
and capybara (Lindert et al., 2008), but has not been found in C. elegans or yeast. 
Human and mouse MTF-1 show 93% sequence identity, the truncated C-terminus of 
the mouse notwithstanding. Vertebrate and insect MTF-1 show only 39% sequence 
similarity of the full-length protein, most of which is accounted for by a 78% 
similarity in the zinc-finger region. 
 
Human MTF-1 harbors a non-canonical nuclear localization signal (NLS) sequence 
overlapping with the zinc-finger domain (Lindert et al., 2009) and a nuclear export 
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signal (NES) sequence that overlaps with the major activation domain (Saydam et al., 
2001). MTF-1 also contains three different transactivation domains C-terminal to the 
DNA binding domain: an acidic, a proline-rich, and a serine/threonine –rich domain. 
 
                                           Human-MTF-1 
 
Drosophila-MTF-1 
 
 
Figure 5: Schematic view of the functional domains of human-MTF-1 (top) and 
Drosophila-MTF-1 (below). Domains of human-MTF.1 include a potentiation 
domain (yellow), C2H2-zinc finger domain (blue), acidic activation domain (green), 
proline-rich domain (orange) and serine/threonine-rich domain (dark blue), auxiliary 
nuclear localization signal (aNLS) (black box on left), nuclear export signal (NES) 
(light green box), cysteine-cluster (red box). Drosophila-MTF-1 domains indicate the 
zinc-finger domain (blue), putative NLS (dark blue), acidic-domain (green), NES1 
and 2 (light green), cys-cluster (red). 
 
 
Targeted disruption of the MTF-1 gene has been achieved in the mouse and in 
Drosophila melanogaster. MTF-1 knockout mice die at the embryonic stage (E13-
E14) due to liver degeneration (Gunes et al., 1998). Drosophila MTF-1 (dMTF-1) 
null mutants are viable but highly sensitive to heavy metal stress and also to copper 
starvation (Egli et al., 2003). dMTF-1 has the unique ability to handle both extremes, 
namely, copper overload and copper scarcity (Selvaraj et al., 2005). Upon copper 
stress, it activates the metallothionein genes, while under copper depletion condition it 
upregulates the copper importer Ctr1B. 
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Metallothioneins and other MTF-1 target genes 
The best characterized target genes of MTF-1 are the metallothioneins. 
Metallothioneins are small proteins of 61-68 amino acids with a very high cysteine 
content (up to 30%) (West et al., 2008). Four metallothionein genes have been 
identified in the mouse. Mt-1 and Mt-2 are ubiquitously expressed and are highly 
inducible in response to various stress conditions (heavy metal ions, hormones, 
cytokines, ROS, inflammation). Mt-3 expression is restricted to the central nervous 
system and Mt-4 to the squamous epithelia, whereby the Mt3 gene contains MRE like 
sequence motifs but appears not to be regulated by MTF-1. Mice with a combined 
knockout of Mt-1 and Mt-2 are viable, in contrast to the MTF-1 knockout mice, 
however, they are sensitive to cadmium and zinc (Kelly et al., 1996; Masters et al., 
1994; Michalska and Choo, 1993). In humans, MT-1 has diverged into a family of 7 
genes (Mt-1A, -B, -E, -F, -G, -H and –X) while the other isoforms are represented by 
only one gene each, Mt-2A, Mt-3 and Mt-4 (Sadhu and Gedamu, 1988; Stennard et 
al., 1994; West et al., 1990). There is increasing evidence for a protective role of 
metallothioneins against neurodegeneration and CNS injury (West et al., 2008).  
 
In Drosophila melanogaster there are at least four metallothioneins, designated 
MtnA-D, which are preferentially expressed in regions of high metal content, such as 
the larval intestinal tract and the midgut. They are induced by cadmium, zinc, copper, 
silver and mercury in an MTF-1 dependent manner (Egli et al., 2006). The quadruple 
knockout of the four Mtns leads to a severely reduced lifespan in males. Furthermore, 
flies are highly sensitive to copper, cadmium and to a lesser extent to zinc during 
development (Egli et al., 2006). Recently a putative fifth Mtn, MtnE, located proximal 
to MtnD was identified (Susan Celniker, Lawrence Berkeley National Laboratory) 
and is currently being investigated in our Lab (L. Atanesyan, H. Hua, O. Georgiev 
and WS, unpublished). 
 
In fungi, metallothionein genes (CUP1 and CRS5 in Saccharomyces cerevisiae) are 
regulated by copper-sensitive transcription factors like Ace1 which have no sequence 
homology to MTF-1 (Rutherford and Bird, 2004). The metallothionein regulating 
transcription factor of Candida glabrata is Amt1 and that of Yarrowia lipolytica 
(dimorphic yeast) is Crf1. All these factors display a significant sequence similarity in 
their N-termini (Garcia et al., 2002). 
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Microarray studies done for the identification of novel target genes of MTF-1 in 
MTF-1 knockout mice, revealed α-fetoprotein, the liver-enriched transcription factor 
C/EBPα and tear lipocalin as new target genes, all of them being involved in stress 
response (Lichtlen and Schaffner, 2001). A zinc transporter, ZnT1 is also under MTF-
1 control in the mouse (Langmade et al., 2000). As part of a screen carried out for 
zinc-responsive transcripts, Kruppel-like factor 4, hepatitis A virus cellular receptor 1 
and complement factor B were also proposed as MTF-1 target genes (Kindermann et 
al., 2005). MTF-1 was shown to be essential for the basal expression of selenoprotein 
W (Sepw1), a putative antioxidant protein having a glutathione binding site (Wimmer 
et al., 2005). With regard to stress response, MTF-1 regulates cadmium-induced 
expression of N-myc downstream regulated gene 1 (Ndrg1) as well as the cadmium 
response of the cysteine- and glycine-rich protein 1 gene (Csrp1) that is involved in 
cytoskeletal organization (Wimmer et al., 2005). MTF-1 downregulates metal 
importers, namely, the zinc transporter, Slc39a10 (ZIP10) (Kaler and Prasad, 2007) 
and in D. melanogaster the copper transporter Ctr1B. Additionally, transcription of 
the gene encoding hypoxia inducible placental growth factor, a pro-angiogenic 
protein, was shown to depend on MTF-1 (Green et al., 2001). Furthermore, siRNA 
knockdown experiments in cell culture suggested a cooperation of MTF-1 with Sp1 in 
the copper dependent positive regulation of the prion protein PrP gene (Bellingham et 
al., 2009). Misfolding of PrP causes transmissible spongiform encephalitis, a 
neurodegenerative disorder termed Creutzfeldt-Jakob disease in humans, BSE in 
cattle and scrapie in sheep. Growing evidence points towards a role of PrP in copper 
homeostasis (Brown et al., 1997; Pauly and Harris, 1998; Ruiz et al., 2000; 
Wadsworth et al., 1999). A search for MTF-1 target genes in Drosophila revealed 
results similar to mammals. MTF-1 targets include metallothioneins (MtnA-D), the 
zinc efflux transporter ZnT35C, the ATP binding cassette (ABC) transporter 
CG10505 and ferritins, which play a major role in iron homeostasis (Egli et al., 2003; 
Yepiskoposyan et al., 2006). Furthermore, dMTF-1 is implicated in the copper-
responsive expression of DmAtp7, the Drosophila ortholog of the Menkes and 
Wilson’s disease proteins Atp7A and Atp7B, in the larval midgut (Burke et al., 2008). 
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All these verified and inferred target genes highlight the central role of MTF-1 in 
metal homeostasis, defense against various stresses like heavy metal toxicity, heat 
shock, ROS and hypoxia as well as in angiogenesis and neuroprotection. 
 
III) Zinc homeostasis 
 
Zinc is an essential heavy metal that functions as a structural component in a number 
of proteins, including transcription factors and enzymes. Accordingly, zinc is 
important for several biological processes, such as nucleic acid metabolism, cell 
growth and proliferation, immune response and brain development. The 
concentrations of cellular zinc are tightly regulated. Uptake and efflux of zinc requires 
transporters which are grouped into two families based on their structure and 
functions. The ZIP protein family (also called as ZRT/IRT-related proteins) import 
zinc from extracellular space or intracellular vesicles into the cytoplasm (Eide, 2004). 
The ZnT proteins are involved in intracellular trafficking and excretion of zinc 
(Liuzzi and Cousins, 2004; Palmiter and Huang, 2004). In mammals, ZIPs are 
encoded by a solute carrier family 39A (SLC39A) genes and ZnTs (ZnT1-7) are 
encoded by solute carrier family 30A (SLC30A) genes (Palmiter and Findley, 1995). 
There are twelve ZIP genes identified so far in humans and three in mouse (Gaither 
and Eide, 2001). Under zinc-limiting conditions mice lacking ZIP1, ZIP2 or ZIP3 are 
embryonic lethal (Dufner-Beattie et al., 2006; Peters et al., 2007). Certain mutations 
in ZIP4 in humans cause a zinc deficiency disorder termed acrodermatitis 
enteropathica (AE) (Wang et al., 2002). Homozygous ZIP4 mutant mice die at early 
embryonic stages while heterozygous mutants are highly sensitive to zinc deficiency, 
similar to AE patients. Furthermore, female mice lacking functional ZnT4, which is 
expressed in breast epithelial cells, have low zinc levels in the milk which is fed to 
their pups, resulting in the death of the pups (Huang and Gitschier, 1997). In 
Drosophila, two ZIP genes have been identified, the fear of intimacy foi which is the 
counterpart of mammalian ZIP6/ZIP10 and catsup which is the counterpart of 
mammalian ZIP 7 (Mathews et al., 2005; Stathakis et al., 1999). One of the ZnTs, 
ZnT35C has been described in Drosophila (Yepiskoposyan et al., 2006). While 
Drosophila MTs preferentially bind copper and cadmium, mammalian MTs 
predominantly bind zinc, at least in non-metal stressed cells (Palmiter and Huang, 
2004). 
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Zinc homeostasis in yeast is controlled primarily through the regulation of zinc uptake 
(Eide, 1997). S. cerevisiae has two separate uptake systems to obtain zinc from its 
environment, a high affinity transporter protein (Zrt1) and a lower affinity transporter 
(Zrt2), both of which are regulated by zinc availability; zinc limitation induces, and 
zinc-replete conditions repress their expression (Zhao et al., 1998). This zinc-
responsive transcriptional regulation requires the regulatory protein Zap1, the 
function of which is repressed in high-zinc conditions (Zhao et al., 1998). Zap 1 binds 
to a conserved sequence, called the zinc response element (ZRE) of consensus 5'-
ACCYYNAAGGT-3' which is present in the Zrt1, Zrt2, Zrt3 and ZAP1 promoters 
(Lyons et al., 2000). 
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Abstract 
 
The mechanisms underlying neuron death in Parkinson's disease are 
unknown, but both genetic defects and environmental factors are 
implicated in its pathogenesis. Mutations in the parkin gene lead to 
autosomal recessive juvenile Parkinsonism (AR-JP). Here we report that 
compared to control flies, Drosophila lacking parkin show significantly 
reduced lifespan but no difference in dopamine neuron numbers when 
raised on food supplemented with environmental pesticides or 
mitochondrial toxins. Moreover, chelation of redox-active metals, anti-
oxidants and overexpression of superoxide dismutase 1 all significantly 
reversed the reduced longevity of parkin-deficient flies. Finally, parkin 
deficiency exacerbated the rough eye phenotype of Drosophila caused by 
overexpression of the copper importer B (Ctr1B). Taken together, our 
results demonstrate an important function of parkin in the protection 
against redox-active metals and pesticides implicated in the etiology of 
Parkinson's disease. They also corroborate that oxidative stress, perhaps 
as a consequence of mitochondrial dysfunction, is a major determinant of 
morbidity in parkin mutant flies. 
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           Introduction 
 
            A combination of mitochondrial dysfunction, oxidative stress and abnormal 
protein aggregation underlies the pathogenesis of PD ([Bueler, 2009], 
[Henchcliffe and Beal, 2008], [Cookson, 2005], [Dawson and Dawson, 2003], 
[Moore et al., 2005] and [Shen and Cookson, 2004]). About 10% of PD cases 
are heritable and caused by mutations in at least five genes ([Gasser, 2009], 
[Hardy et al., 2009] and [Hatano et al., 2009]). Parkin (PARK2) mutations 
lead to autosomal recessive juvenile Parkinsonism (AR-JP) ([Abbas et al., 
1999] and [Kitada et al., 1998]). Parkin functions as an E3 ubiquitin ligase in 
the proteasome-mediated turnover of several proteins in vitro ([Corti et al., 
2003], [Imai et al., 2001], [Shimura et al., 2000] and [Zhang et al., 2000]), 
some of which accumulate in the brains of AR-JP patients and/or mice 
carrying a targeted deletion of the Parkin gene ([Fukae et al., 2009], 
[Murakami et al., 2004] and [Periquet et al., 2005]). Ablation of Parkin in 
mice resulted in mitochondrial respiratory defects, decreased levels of anti-
oxidant proteins (Palacino et al., 2004) and abnormalities in dopamine 
neurotransmission, but not loss of dopamine neurons ([Goldberg et al., 2003] 
and [Itier et al., 2003]). Recently, Parkin has been linked to DNA repair ([Kao, 
2009a], [Kao, 2009b] and [Rothfuss et al., 2009]). Parkin was shown to 
enhance the replication, transcription and repair of mitochondrial DNA, 
thereby protecting mitochondrial DNA against oxidative damage (Rothfuss et 
al., 2009). Drosophila lacking Parkin display increased sensitivity to oxidative 
stress and severe structural mitochondrial abnormalities in muscle and 
germline tissues associated with apoptotic muscle degeneration and male 
sterility ([Greene et al., 2005], [Greene et al., 2003] and [Pesah et al., 2004]). 
There is controversy as to whether or not frank dopamine neuron death occurs 
in flies with parkin loss-of-function mutations. Limited dopamine neuron 
death restricted to the PPL1/DL1 cluster has been detected in 20-day-old 
parkin mutant flies (park25 allele) by tyrosine hydroxylase (TH) 
immunohistochemistry combined with whole-mount confocal microscopy 
(Whitworth et al., 2005). However, the original characterization of the same 
flies showed that dopamine neuron numbers determined in paraffin-embedded 
sections were normal, even in older Drosophila (30 days) (Greene et al., 
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2003). Another line of parkin mutant flies (Pesah et al., 2004) also lacked 
dopamine neuron death, but the PPL1 cluster showing neuron loss (Whitworth 
et al., 2005) was not analyzed in this study. Although (Greene et al., 2003) and 
(Whitworth et al., 2005) used different methods to quantify TH neurons, it 
cannot be concluded that confocal microscopy is more likely to detect TH 
neuron loss than using paraffin-embedded sections. In fact, in α-synuclein 
transgenic flies, TH neuron loss was detected using paraffin-embedded 
sections (Feany and Bender, 2000), but not with whole-mount confocal 
microscopy (Pesah et al., 2005), although both groups used the same flies 
again. Finally, several groups failed to detect dopamine neuron loss in Parkin-
deficient mice ([Goldberg et al., 2003], [Itier et al., 2003] and [Palacino et al., 
2004]). Taken together, the data suggest that Parkin ablation may lead to 
neuron death in one of several dopamine neuron clusters in the Drosophila 
brain, while Parkin appears to be dispensible for dopamine neuron survival in 
mice. 
 
            Several epidemiological studies showed that long-term exposure to pesticides, 
such as rotenone and paraquat, correlates with an increased risk of developing 
idiopathic PD ([Abbott et al., 2003], [Baldi et al., 2003], [Gorell et al., 1998] 
and [Petrovitch et al., 2002]). Intravenous administration of an illicit drug, 
which contained 1-methyl 4-phenyl 1,2,3,6-tetrahydropyridine (MPTP), 
caused an acute and permanent state of Parkinsonism in humans (Langston et 
al., 1983). Moreover, excessive accumulation of iron in the substantia nigra 
has been implicated in PD pathogenesis ([Dexter et al., 1992], [Friedman et 
al., 2007] and [Zecca et al., 2004]). Free iron is toxic to cells as it acts as a 
catalyst in the formation of free radicals from hydrogen peroxide (H2O2) via 
the Fenton reaction (Orino et al., 2001). Because H2O2 is a normal product of 
the dopamine metabolism, dopaminergic neurons may be particularly 
vulnerable to accumulation of free iron. Support for increased free iron levels 
in PD comes form studies that showed reduced amounts of l-ferritin, which is 
important for iron sequestration (Harrison and Arosio, 1996), in PD compared 
to control brains ([Connor et al., 1995] and [Koziorowski et al., 2007]). In 
addition to iron, copper toxicity may play a role in various neurological 
disorders (Desai and Kaler, 2008). In Wilson's disease, increased copper 
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accumulation leads to liver dysfunction and neurological symptoms (Ala et al., 
2007). Interestingly, patients with Wilson's disease often present with 
parkinsonism (Oder et al., 1993 W. Oder et al., Wilson's disease: evidence of 
subgroups derived from clinical findings and brain lesions, Neurology 43 
(1993), pp. 120–124. View Record in Scopus | Cited By in Scopus (59)Oder et 
al., 1993) and deficits in dopamine neurotransmission have been reported 
(Barthel et al., 2003). Furthermore, neurological symptoms were shown to 
correlate with accumulation of copper in brain areas affected in PD, such as 
the basal ganglia and substantia nigra (Sudmeyer et al., 2006). This suggests 
that the nigrostriatal system may be particularly sensitive to copper 
accumulation. In agreement with this notion, long-term occupational exposure 
to copper was associated with an increased risk for PD (Gorell et al., 1997), 
and treatment of cultured dopaminergic neurons with copper led to 
mitochondrial defects, decreased dopamine content and cell death (Shi et al., 
2008). 
 
            Because no single, unified mechanism leads to PD, it has been postulated that 
exogenous and/or endogenous stress factors may synergize with genetic 
defects to cause the precipitation of PD. This “gene–environmental factor 
interaction hypothesis” states that mutations in familial PD genes may 
increase the vulnerability to PD-associated environmental factors and toxins. 
Here, we hypothesized that parkin represents a genetic susceptibility factor in 
the vulnerability of flies to redox-active metals, pesticides and mitochondrial 
toxins implicated in PD. To test this hypothesis, flies carrying a null mutation 
(park25/25) of the Drosophila homologue of parkin (Greene et al., 2003) were 
raised on food supplemented with redox-active metals, metal chelators, 
rotenone, paraquat and MPP+, and their survival was compared to park25/+ 
control flies. The interaction of copper with parkin deficiency was further 
studied in flies overexpressing the copper importer Ctr1B. Finally we 
increased the anti-oxidant defense in flies by various means to corroborate the 
causative role of oxidative stress in the reduced longevity observed in parkin-
deficient flies. Our results demonstrate that loss of Parkin can greatly increase 
the flies' vulnerability to environmental factors, mitochondrial toxins and 
certain redox-active metals implicated in the etiology of PD, and reinforce that 
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oxidative stress is a major pathway in causing the morbidity of parkin-
deficient flies. 
 
            Materials and methods 
            Fly stocks and maintenance 
 
            All flies were maintained at 25 °C on a 12:12 h light–dark cycle. Unless 
specified otherwise, heterozygous parkin mutant flies (w;+;park25/TM6B, 
w+, hereafter referred to as park25/+) were used as controls for the 
homozygous parkin mutant flies (w;+;park25/park25, hereafter referred to as 
park25/25). park25/25 is null mutation of the Drosophila parkin gene (Greene 
et al., 2003). The TM6B balancer in the control flies was confirmed to have no 
effect on any of the experiments performed (by having it crossed out). The 
w;UAS-SOD1/Cyo;+ line expressing SOD1 under the mesoderm-specific 
twist-Gal4 driver (Greig and Akam, 1993) was received from the Bloomington 
stock center. These flies were crossed to the w;+;park25/TM6B,w+ and twi-
Gal4;+;+ flies to obtain twi-Gal4;UAS-SOD1;park25/+ animals, which were 
bred to obtain twi-Gal4;UAS-SOD1;park25/25 flies. The Ctr1B coding region 
was amplified by PCR (with primers 5'-
TGGACTAGATCTCAACATGGATCACGGCTCGGAT-3' and 5'-GTCAGT-
AGATCTCTAAGGACAGCACTCGCT-3') from a Ctr1B cDNA clone and 
inserted into the SmaI site of pBluescript (Stratagene). The resulting construct 
was digested with EcoRI and NotI and the fragment was cloned between the 
EcoRI and NotI sites of the P element vector pUAST. The GMR-Ctr1B 
transgenic flies were generated with a Ctr1B ORF driven by the eye-specific 
GMR promoter/enhancer. The w;GMR-Ctr1B/Cyo; park25/+ transgenic flies 
were obtained by crossing the w;GMR-Ctr1B/Cyo flies with w;+;park 
25/TM6B, w+ flies. 
 
            Preparation of fly food for oxidative stress, metal toxicity and metal 
chelator experiments 
 
            One liter standard fly food (normal food, NF) contained 55 g cornmeal, 10 g 
wheat flour, 100 g yeast, 75 g glucose, 8 g agar and 15 ml anti-fungal agent 
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nipagin (15% in ethanol). Normal food was supplemented with 200 µM 
rotenone, 10 mM paraquat and 25 mM 1-methyl-4-phenylpyridinium iodide 
(MPP+) (final concentrations, all from Sigma). For the metal 
toxicity/chelation and antioxidant experiments, normal food was 
supplemented with 500 µM ammonium ferric citrate, 500 µM copper (II) 
sulfate, 0.3 mM bathocuproine disulfonate (copper chelator), 0.1 mM 
bathophenanthroline sulfonated sodium salt (iron chelator), 20 or 50 µM silver 
nitrate, 15 mM N-acetyl-cysteine and 100, 250 or 500 mM ascorbic acid. 
 
            Lifespan determination 
 
            Lifespan (survival) experiments were carried out in triplicate. In each 
experiment, twenty 1- to 2-day-old flies per genotype were analyzed. 
Surviving flies were counted daily and transferred to fresh food vials every 
second day, with the exception of the SOD1 overexpression experiment where 
flies were counted only on the four indicated days. As a control, flies of the 
same genotype were grown on food lacking the toxins, metals, metal-chelating 
agents or antioxidants. The variations in the average lifespan of control flies in 
different experiments can be attributed to subtle experimental variations. 
 
             Exposure to hypoxia and heat shock 
 
            park25/+ and park25/25 flies (six sets of 20 flies each) were exposed for 7 
min to 0.5% oxygen at 25 °C in a closed hypoxia chamber, and the time to 
regain consciousness (ability to move) was recorded. To achieve a stable 
atmosphere of 0.5% oxygen, ambient air was mixed with nitrogen gas 
(Digamix M302 a-F, H Wösthoff e.H.G) and pumped into the chamber 
(VENT2 pump, EMKA Technologies) for 4 min at a flow rate of 25 l per 
minute. In the heat shock experiment, flies were incubated at 38 °C for 30 or 
60 min and surviving animals were counted 24 h later. 
 
            Quantification of food uptake (gustatory assay) 
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            For the adult gustatory assay, we performed a protocol similar to the one 
described by Hilliker and colleagues (Bahadorani et al., 2008). Briefly, newly 
eclosed flies were reared on normal food for 2–3 days before being starved for 
18 h on Whatman paper soaked with distilled water. Subsequently, starved 
flies (n = 20) were transferred into a vial with fresh normal food (control) or 
chelator-supplemented food, both containing 0.2 % sulforhodamine B sodium 
salt (acid-red), and allowed to feed for 2 h. After 2 h of feeding, flies were 
decapitated and their bodies (without heads) were homogenized individually 
in 100 µl ice-cold buffer (0.32 M sucrose, 20 mM HEPES, 1 mM MgCl2, 0.5 
mM PMSF, pH 7.4). 50 µl of the homogenate supernatants were transferred to 
separate wells of a microtiter (ELISA) plate and absorbance was measured at 
565 nm (absorbance maximum for acid-red) using a multi-label counter 
(Wallac 1429, Perkin Elmer). 
 
            Quantification of brain ROS levels 
 
           Twenty heads dissected from adult flies were homogenized in 3 volumes of 
ice-cold buffer (0.32 mM sucrose, 20 mM HEPES, 1 mM MgCl2, 0.5 mM 
PMSF, pH 7.4) and centrifuged for 20 min at 4 °C at 20,000g. Total protein 
concentration in the supernatant was measured with the Bradford method 
(Biorad kit) and adjusted to 0.4 µg/µl. 20 µl sample (8 µg protein) was mixed 
with 2 µl 40 µM DCF-DA in a fluorimeter cuvette (Hellma, 1.5 × 1.5 mm). 
Excitation and emission maxima of DCF are at 485 nm and 520 nm, 
respectively. The shutter size of the fluorimeter was fixed at 2.5 nm and 
sample fluorescence intensity was monitored for 45 min at 26 °C between 500 
and 600 nm. Fluorescence intensity was recorded every 5 min. The maximum 
peak values were then read as the final value, by integrating the area under the 
peak of the graphs. 
 
            Analysis of eye phenotype 
 
            Flies were frozen at −20 °C and pictures of their eyes were taken with a 
scanning electron microscope (model JEOL JSM-630LV) in the imaging 
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facility of the University of Zurich. Ten eyes per genotype and treatment 
condition were analyzed. 
 
            Detection of TH-positive neurons in brain sections by DAB 
immunohistochemistry 
 
            Flies were lined up on a Heisenberg collar and fixed in Carnoy's solution 
(60% dried ethanol, 30% chloroform, 10% acetic acid) overnight at 4 °C 
(Heisenberg and Böhl, 1979). They were then dehydrated for 40 min in 
absolute ethanol, twice for 40 min in dried ethanol and twice for 60 min in n-
butanol. Paraffin-embedded flies were decapitated, cut into 5-micron-thick 
sections and transferred to Super Frost Plus slides. Slides were placed in xylol 
for 2–5 min for de-waxing and then transferred to absolute ethanol for 2–5 
min, before incubation in 95% ethanol for 2–3 min. Then they were placed 
into 70% ethanol for 2–3 min and the ethanol was washed out. Sections were 
fixed in 0.5% formaldehyde/phosphate-buffered saline (PBS) for 30 min, 
rinsed three times in PBS and blocked by incubation for 30 min in 1% bovine 
serum albumin/0.05% Triton X-100. After washing four times for 5 min in 
PBS/0.05% Triton X-100 they were incubated in PBS/1% bovine serum 
albumin (4 °C overnight) with 1:200 diluted monoclonal anti-tyrosine 
hydroxylase antibody specific for dopamine neurons (Chemicon, MAB 318). 
After five washes with PBS/0.05% Triton X-100, 1:1000 diluted secondary 
biotin-conjugated goat anti-mouse IgG (Jackson ImmunoResearch) was added 
and the sections were incubated for 2 h at room temperature. Finally, they 
were washed five times with PBS and TH neurons were stained with 3,3'-
diaminobenzidine (DAB) using the Vectastain Elite ABC Kit (Vector 
Laboratories). 
 
            Quantification of TH neurons in whole mount Drosophila brains by 
confocal microscopy 
 
            Fly brains were isolated and fixed for 2 h on ice in 100 mM Pipes/2 mM 
magnesium sulphate/1 mM EDTA/4% formaldehyde. They were rinsed twice 
with PBST (PBS/0.1% Tween-20), post-fixed with ice-cold methanol for 3 
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min, rinsed at least four times with PBST and blocked in PBST/10% fetal 
bovine serum (FBS) for 1 h at room temperature. They were then incubated in 
PBST/2% FBS with 1:200 diluted mouse anti-tyrosine hydroxylase antibody 
(Chemicon, MAB318) for at least 36 h at 4 °C, washed three times for 1 h in 
PBST at 4 °C, and incubated at 4 °C overnight with 1:500 diluted goat anti-
mouse IgG conjugated to Alexa 488 (Invitrogen) in PBST/2% FBS. After 
three 1-h washes in PBST, the brains were mounted in 80% glycerol/0.1 M 
Tris-HCl pH 7.5. TH-positive neurons of the DM and DL1 clusters were 
counted in about thirty 2 micron-thick confocal brain sections per fly. 
 
            Statistical analysis 
 
            JMP software (SAS Institute) was used for statistical evaluations. Lifespan 
(survival) assays were analyzed with the Kaplan–Meier log-rank statistical 
test. Brain ROS levels were compared by one-way ANOVA. For all other 
experiments, data were compared using the Student's t-test. Results are 
expressed as mean ± standard deviation. 
 
            Results 
            Increased vulnerability of parkin-deficient Drosophila to environmental 
pesticides and mitochondrial toxins associated with Parkinson's disease 
 
            For our studies we used the park25/25 flies in which 75% of the Parkin coding 
sequence, including the start codon, had been removed by imprecise excision 
of a P-element insertion at the 5' end of the fly parkin gene (Greene et al., 
2003). The deletion is thus a parkin null allele. As controls, we used park25/+ 
(heterozygous mutant parkin) flies. To investigate whether parkin deficiency 
increases the susceptibility to environmental substances that are known to 
cause oxidative stress and have been associated with PD ([Abbott et al., 2003], 
[Dauer and Przedborski, 2003], [Langston et al., 1983] and [Petrovitch et al., 
2002]), we compared the survival of park25/25 and park25/+ flies exposed to 
rotenone, MPP+ and paraquat. Flies were raised on food supplemented with 
200 µM rotenone, 25 mM MPP+ or 10 mM paraquat and their survival was 
monitored daily (Fig. 1). The toxin concentrations we used were in the range 
 60 
reported for the same pesticides in Drosophila in previous publications, 
namely 2–40 mM for paraquat ([Jones et al., 2009], [Lee et al., 2009], [Pesah 
et al., 2004], [Schriner et al., 2009] and [Wang et al., 2008]) and 25–500 µM 
for rotenone ([Coulom and Birman, 2004], [Hosamani and Muralidhara, 
2009], [Wang et al., 2007] and [Wang et al., 2008]). For MPP+, we found no 
reference for Drosophila and choose a concentration that is at least 25 times 
higher than required to induce significant cell death in mammalian 
neuroblastoma cells (Bando et al., 2005). park25/25 flies were more sensitive 
to and showed significantly shortened lifespan after treatment with all three 
toxins, when compared to either park25/+ (p < 0.001) or yw (p < 0.001) 
controls (Fig. 1A–C). In contrast, park25/+ flies were not more vulnerable to 
the toxins than yw control flies. All toxins further reduced the lifespan of 
park25/25 Drosophila (p < 0.01), showing that the experiment was able to 
detect an effect of the toxins on the parkin-deficient background. 
Unexpectedly, park25/+ flies displayed increased lifespan compared to yw 
control flies on MPP+, an observation that we have not investigated further 
and for which we have no explanation at present. We believe it is unlikely that 
park25/+ flies developed mitochondrial resistance to MPP+, because both 
MPP+ and rotenone are potent inhibitors of the mitochondrial complex I, but 
park25/+ flies are not resistant to rotenone (Fig. 1A). 
 
            Lack of dopamine neuron death in Parkin-deficient flies exposed to 
environmental toxins 
 
            Although dopamine neurons of mice, and most of the dopamine neuron 
clusters in flies, survive in the absence of Parkin ([Goldberg et al., 2003], 
[Greene et al., 2003], [Itier et al., 2003], [Pesah et al., 2004] and [Whitworth et 
al., 2005]), mitochondrial abnormalities and the upregulation of components 
of the oxidative stress response in parkin-deficient Drosophila suggested that 
Parkin generally functions to protect mitochondria and cells against oxidative 
stress ([Greene et al., 2005], [Greene et al., 2003] and Palacino et al., 2004 J.J. 
Palacino et al., Mitochondrial dysfunction and oxidative damage in parkin-
deficient mice (Palacino et al., 2004]). Given the reduced lifespan of 
park25/25 flies exposed to pesticides and MPP+ (Fig. 1), we tested whether 
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dopamine neurons of parkin null flies are more sensitive to oxidative stress 
and mitochondrial complex I inhibition evoked by the same toxins. Dopamine-
synthesizing neurons in whole Drosophila brains were identified with an 
antibody against tyrosine hydroxylase (TH). To maximize the chance of 
detecting a degenerative process, brains of survivors were analyzed when at 
least 50% of the parkin-deficient flies had died. Owing to the small size of the 
fly brain, TH-positive neurons could be directly counted in serial optical 
sections of whole-mount fly brains using confocal laser microscopy (Fig. 2A 
and B). Drosophila dopamine neurons are organized in several distinct 
clusters. We quantified the number of dopamine neurons of the protocerebral 
posterior lateral (PPL1, also named DL1) and protocerebral posterior medial 
(PPM, also named DM) clusters (Whitworth et al., 2005). However, no 
differences in the numbers of TH-positive neurons between wild type and 
parkin null flies exposed to the various toxins were observed (Fig. 2C and D). 
 
            Sequestration of redox-active trace metals prolongs the lifespan of parkin 
mutant flies 
 
            As discussed above, trace metals can be toxic when insufficiently sequestered 
and have been implicated in several neurodegenerative disorders ([Friedman et 
al., 2007], [Rhodes and Ritz, 2008], [Rossi et al., 2004], [Sayre et al., 1999], 
[Zatta et al., 2009] and [Zecca et al., 2004]). To investigate whether parkin 
deficiency may sensitize flies to endogenous iron and copper toxicity, 
park25/25 Drosophila were raised on food supplemented with chelators of 
copper and iron. We used the copper-specific chelator bathocuproine 
disulfonate (BCS) and bathophenanthroline sulfonated sodium salt (BPS), 
which preferentially sequesters iron and to a lesser degree copper. Various 
concentrations of the chelators were tested. We found that both 0.1 mM BPS 
and 0.3 mM BCS significantly prolonged the median lifespan of park25/25 
flies, which was 5 days on normal food (Fig. 3A). In addition, the combination 
of BPS and BCS extended the median lifespan even more to 19 days (Fig. 
3A). In contrast, metal chelation did not increase the lifespan of park25/+ flies 
observed up to 50 days of age (data not shown). Because increased longevity 
has been associated with calorie restriction in several species including 
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Drosophila (Guarente and Picard, 2005), we wanted to exclude the possibility 
that the flies consumed reduced amounts of food containing metal chelators. 
For this purpose we carried out the adult gustatory assay and quantified for 
food uptake. This assay results in red abdomen coloration due to the chemical 
acid-red mixed into the food ([Bahadorani et al., 2008] and [Orgad et al., 
1998]). As shown in Fig. 3B and C, there was no difference in the amount of 
food ingested by park25/25 and park25/+ flies grown on metal chelator-
supplemented food, compared to normal food. This demonstrates that parkin 
mutant flies were not repelled from eating food containing metal chelators. 
Therefore, our results show that the increased lifespan of parkin mutant flies is 
due to metal chelation and suggest that parkin mutants are more sensitive to 
endogenous levels of the redox-active metals iron and copper, which have 
been implicated in PD ([Desai and Kaler, 2008], [Friedman et al., 2007], 
[Hirsch, 2006], [Wright et al., 2009] and [Zecca et al., 2004]). The 
mechanisms by which iron and copper chelators increased the lifespan of 
parkin-deficient flies are unknown, but possibly include reduced oxidative 
stress, as both iron and copper have the ability to accept and donate electrons. 
This can lead to formation of ROS and oxidative modification of proteins, 
lipids and other cell constituents ([Barnham and Bush, 2008] and [Halliwell 
and Gutteridge, 1990]). Consistent with this idea, heads of parkin-deficient 
flies raised on chelator-supplemented food showed a reduced level of ROS 
measured by 2',7'-dichlorofluorescin diacetate (DCF-DA), a cell-permeable 
non-fluorescent dye that turns highly fluorescent upon oxidation within cells 
(Fig. 3D). DCF fluorescence of isolated park25/25 brains, as observed in the 
confocal microscope, was also significantly lower in presence of metal 
chelators (Fig. 3D, inset). To further probe an interaction of iron and copper 
with parkin deficiency, we exposed park25/25 and park25/+ flies to increased 
levels of iron and copper. Iron slightly but significantly reduced the lifespan of 
park25/25 flies (p < 0.01) without exerting an effect on park25/+ flies (Fig. 
3E). In contrast, increasing the copper concentration in the food failed to 
shorten the lifespan of either genotype of flies (Fig. 3F). It is possible that 
uptake of iron and copper is subject to different regulation, and that excess 
copper in the food not necessarily results in increased copper uptake through 
the copper transporter (see Discussion). 
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            Lack of Parkin aggravates the rough eye phenotype caused by 
overexpression of the Ctr1B copper importer 
 
            High affinity copper transporters are present in all eukaryotes including 
Drosophila, which encodes three members (Ctr1A, B and C) ([Dancis et al., 
1994], Lee et al., 2000 J. Lee et al., Isolation of a murine copper transporter 
gene, tissue specific expression and functional complementation of a yeast 
copper transport mutant ([Lee et al., 2000], [Selvaraj et al., 2005], [Turski and 
Thiele, 2009] and [Zhou et al., 2003]). Ectopic overexpression of the 
Drosophila Ctr1B gene results in copper hypersensitivity leading to death 
when flies are grown on food with normal copper content (Selvaraj et al., 
2005). To study whether parkin deficiency may sensitize to copper-mediated 
cell death in the eye, we overexpressed Ctr1B under the control of the eye-
specific GMR promoter in park25/+ and park25/25 Drosophila. Control 
GMR-Ctr1B transgenic flies showed normal eyes when grown on regular food 
(Fig. 4A), but developed a rough eye phenotype in presence of 20 µM copper 
(Fig. 4B). park25/25 Drosophila also had normal eyes (Fig. 4C). In contrast, 
GMR-driven overexpression of Ctr1B in park25/25 flies resulted in a rough 
eye phenotype, even on regular food (Fig. 4D). This phenotype was alleviated 
by copper scarcity and exacerbated by increased copper levels (data not 
shown). Importantly, the rough eye phenotype was not observed when Ctr1B 
was overexpressed in the eyes of park25/+ flies (Fig. 4E). These results show 
that loss of Parkin and Ctr1B overexpression synergize in the induction of the 
rough eye phenotype, and suggest that parkin deficiency increases the 
vulnerability to increased copper import through Ctr1B. To investigate 
whether the phenotype was indeed specific for copper, park25/25 flies 
overexpressing Ctr1B were raised on food supplemented with 20 µM or 50 
µM silver nitrate (AgNO3). Silver effectively competes with and inhibits 
copper import through the human transporter hCtr1 (Lee et al., 2002) but, in 
contrast to copper, does not promote oxidative stress by engaging in cellular 
redox reactions. Silver failed to cause a rough eye phenotype in park25/25 
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flies overexpressing Ctr1B (Fig. 4F–G), showing that this phenotype was 
specific to copper and likely depends on copper-mediated oxidative stress. 
 
            Beneficial effects of antioxidants and SOD1 overexpression on parkin-
deficient flies 
 
            Because the studies described above suggested that reduced ROS production 
may, at least in part, be responsible for the increased lifespan of parkin-
deficient flies raised on metal chelator-supplemented food (Fig. 3A and D), we 
further investigated the role of oxidative stress in the reduced longevity of 
park25/25 flies and the effect of combined anti-oxidant and metal chelator 
treatment on the survival of park25/25 flies. Cytosolic Cu/Zn superoxide 
dismutase (SOD1), catalase and glutathione reductase provide the first line of 
defense against ROS. In addition, the glutathione precursor N-acetylcysteine 
(NAC), which can be taken up by cells, reduces oxidative stress through its 
ability to scavenge free radicals. Ascorbic acid (vitamin C) is the most 
important water-soluble antioxidant and protects cellular DNA and low-
density lipoproteins from oxidative damage by quenching free radicals (Duarte 
and Lunec, 2005). Both 15 mM NAC (Fig. 5A) and 100 mM ascorbic acid 
(Fig. 5B) significantly increased the median lifespan of park25/25 flies from 5 
days to 14 days (NAC) and 10 days (ascorbic acid). However, higher 
concentrations of ascorbic acid were ineffective and even shortened lifespan. 
Although this was unexpected, studies in humans have shown that optimal 
dosing of vitamin C is critical to achieve beneficial effects (Padayatty et al., 
2003). Flies grown on food containing both NAC and metal chelators had a 
longer maximum lifespan (>38 days) than either flies grown on NAC-
supplemented food alone (22 days) or metal chelators alone (30 days). 
However, the median lifespan of flies treated with NAC and metal chelators 
(15 days) was similar to flies treated with NAC alone (14 days), suggesting 
that the combination of both treatments provides no further benefit on overall 
survival (although it extends maximum lifespan). Collectively, these results 
suggest that the lifespan-extending effect of metal chelation is at least partially 
mediated through the reduction of oxidative stress. Next, we compared the 
survival of parkin-deficient flies with or without overexpression of SOD1 in 
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mesoderm-derived tissues. In this experiment, survival was monitored at the 
four specific ages indicated in Fig. 5C. SOD1-expressing park25/25 flies up to 
4 days of age did not show a difference in survival compared to non-
transgenic park25/25 flies (Fig. 5C). However, at 11 days of age only 10% of 
the park25/25 flies were alive compared to 80% of the park25/25 flies 
overexpressing SOD1. None of the park25/25 flies survived to 17 days at 
which time point 80% of the SOD-1 expressing park25/25 animals were still 
alive (Fig. 5C). In conclusion, both non-enzymatic and enzymatic reduction of 
oxidative stress and ROS led to increased survival of park25/25 flies. The 
effect of SOD1 was particularly strong, perhaps because thetwi-GAL4 driver 
results in enhanced SOD1 expression in flight muscles ([Estrada et al., 2007] 
and [Greig and Akam, 1993]), which underwent apoptotic degeneration in 
parkin-deficient Drosophila (Greene et al., 2003). 
 
            Loss of parkin leads to increased susceptibility to hypoxia and heat shock 
 
            It has been proposed that Parkin functions as a multipurpose neuroprotective 
agent in the defense against oxidative stress and the accumulation of specific 
Parkin substrates ([Feany and Pallanck, 2003] and [Moore, 2006]). In 
addition, parkin mutant flies were reported to be more sensitive to cold stress 
(Pesah et al., 2004). A recent study identified an E3 ligase complex comprised 
of Parkin and two other recessive PD-associated proteins, PINK1 and DJ-1 
(PPD complex), whose function is to degrade unfolded and misfolded proteins 
(Xiong et al., 2009). In order to analyze whether Parkin may also protect 
against non-oxidative stressors and conditions that induce global protein 
denaturation and aggregation, we exposed park25/25 and park25/+ flies to 
transient hypoxia and heat shock. The cellular response to hypoxia is 
conserved in Drosophila (Lavista-Llanos et al., 2002) and the recovery from 
oxygen deprivation is significantly delayed by mutations in hypnos genes 
(Haddad et al., 1997), one of which encodes an RNA-directed adenosine 
deaminase (ADAR) (Ma et al., 2001). ADAR is known to edit the transcripts 
of at least three fly ion channels, suggesting that regulation of specific ion 
channels might be important for recovery from hypoxia (Ma et al., 2001). 
Interestingly, the recovery of park25/25 flies from a 7-min exposure to 0.5% 
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oxygen in a hypoxia chamber was also significantly delayed when compared 
to park25/+ control flies (Fig. 6A). In addition, a heat shock for 30 or 60 min 
at 38 °C resulted in dramatically increased mortality in the absence of Parkin, 
with only 15% and 7% of the park25/25 flies surviving, while at least 95% of 
park25/+ control flies survived the same treatments (Fig. 6B). These results 
suggest that the protective function of Parkin extends to non-oxidative 
stressors and conditions that impair global protein homeostasis. 
 
            Discussion 
 
            Here, we addressed whether the lack of Parkin sensitizes flies to 
environmental pesticides, mitochondrial toxins and metals that have been 
implicated as risk factors in the etiology of Parkinson's disease. Earlier studies 
in Drosophila had shown that parkin ablation increased the vulnerability of 
flies to paraquat (Pesah et al., 2004), but other toxins and metals have not been 
studied previously. Our experiments confirm the reduced lifespan after 
exposure to paraquat and show that Parkin-deficient flies are also more 
sensitive to the mitochondrial complex I inhibitors rotenone and MPP+. In 
rats, chronic and systemic exposure to rotenone reproduces features of PD, 
including nigrostriatal degeneration and α-synuclein-positive cytosolic 
inclusions ([Betarbet et al., 2000] and [Sherer et al., 2003]). Drosophila 
expressing mutant forms of LRRK2 exhibited late-onset dopamine neuron loss 
that was aggravated by rotenone (Ng et al., 2009). Interestingly, co-expression 
of human Parkin conferred significant protection against rotenone-induced 
dopamine neuron loss in LRRK2 G2019S transgenic flies, suggesting that 
Parkin reversed the increased rotenone sensitivity caused by mutant LRRK2 
(Ng et al., 2009). MPP+ is the toxic metabolite of MPTP, which caused an 
acute and permanent state of Parkinsonism in humans ([Langston et al., 1983] 
and [Langston and Ballard, 1983]). This discovery subsequently led to the 
development of MPTP-based PD models in monkeys and mice ([Burns et al., 
1983] and [Heikkila et al., 1984]). While both rotenone and MPP+ 
significantly shortened the lifespan of park25/25 Drosophila, we failed to 
detect an adverse effect of these chemicals on the survival of dopamine-
synthesizing (tyrosine hydroxylase-positive) neurons in these flies. The same 
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was true for paraquat that is known to produce nigrostriatal dysfunction and 
degenerative changes reminiscent of PD in mice ([Brooks et al., 1999], 
[Manning-Bog et al., 2002] and [McCormack et al., 2002]). Although no loss 
of TH-positive neurons was observed in park25/25 flies, we cannot exclude 
the possibility that dopamine neuron death may occur after longer toxin 
exposure in parkin mutant flies. Limited dopamine neuron death restricted to 
the PPL1 cluster has been reported in 20-day-old parkin mutant flies (park25 
allele) (Whitworth et al., 2005). However, the original characterization of the 
same flies showed that dopamine neuron numbers were normal, even in 30-
day-old Drosophila (Greene et al., 2003). In addition, although we used the 
same flies, the maximum lifespan of park25/25 flies was only 10–13 days in 
different experiments in our hands (see Figs. 1C, 3A, E, 5A–B), preventing us 
from analyzing dopamine neuron numbers at later ages. Alternatively, feeding 
the toxins may not result in their accumulation in the brain at concentrations 
sufficiently high to affect neurons. In this regard, it is noteworthy that flies 
with a knockout of DJ-1, another gene associated with Parkinsonism, also 
displayed a shortened lifespan but no dopamine neuron death when exposed to 
paraquat and rotenone ([Menzies et al., 2005] and [Meulener et al., 2005]). 
Collectively, these results show that the dopaminergic system of flies is 
largely insensitive to paraquat, rotenone and MPP+ (at least under the 
conditions used here), but that lifespan determination is a feasible strategy to 
assess the effects of a specific gene ablation on susceptibility to PD-associated 
toxins and other factors. Therefore, in all subsequent studies we focused on 
the survival of parkin-deficient flies compared to park25/+ Drosophila to 
determine whether a given treatment affected the flies in a parkin-dependent 
manner. 
 
            Iron and copper have been implicated in the pathogenesis of various 
neurodegenerative disorders ([Chinta and Andersen, 2008], [Desai and Kaler, 
2008], [Rhodes and Ritz, 2008], [Waggoner et al., 1999], [Zatta et al., 2009] 
and [Zecca et al., 2004]). The total iron content is increased in the substantia 
nigra in PD, and a shift in the Fe3+/Fe2+ ratio with a higher level of reactive 
labile Fe2+ may contribute to increased oxidative stress in PD (Berg and 
Hochstrasser, 2006). In our experiments, we found that park25/25 but not 
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park25/+ flies showed decreased lifespan when grown on iron-supplemented 
food. Moreover, addition of the iron-chelating agent BPS to food containing 
normal levels of iron increased the lifespan of parkin-deficient flies. Likewise, 
mixing the copper-chelating agent BCS into the food significantly increased 
the lifespan of park25/25 flies, and the combination of both BCS and BPS 
extended lifespan even more. In contrast, park25/+ flies showed similar 
survival curves up to 50 days of age when grown on either normal or chelator 
(BPS + BCS) -supplemented food (data not shown), indicating that 
sequestration of free iron and copper benefited flies only in the absence of 
Parkin. Given that sequestration of copper extended the lifespan of park25/25 
Drosophila, we were surprised to find that increased concentrations of copper 
in the food did not impair survival of parkin-deficient flies. It is conceivable 
that the uptake of copper is tightly regulated and not proportional to the 
amount of copper added to the food. In fact, copper uptake by the human 
Ctr1transporter (hCtr1) was saturated at about 25 µM copper (Lee et al., 
2002), a concentration that is 20 times lower than we used in the copper 
feeding experiment (Fig. 3E). In contrast, overexpression of the copper 
transporter Ctr1B in the eye of park25/25 flies resulted in a rough eye 
phenotype even on food with normal copper concentration, while this 
phenotype was not observed in park25/+ controls. Because it has been shown 
that overexpression of hCtr1 increases copper uptake even at low copper 
concentrations (Lee et al., 2002), these results suggest that the uptake, rather 
than availability of copper in the food, may be limiting for toxicity in 
park25/25 flies. Compared to park25/+ control flies, park25/25 animals 
showed significantly increased levels of ROS in the head/brain, as measured 
by DCF fluorescence. Rearing park25/25 flies on food containing iron- and 
copper-chelating agents decreased the ROS levels, suggesting that reduction 
of oxidative stress through sequestration of redox-active iron and copper may 
be responsible for the lifespan extension observed under these conditions. In 
agreement with this idea, transcriptional profiling of Drosophila parkin 
mutants revealed that genes of the oxidative stress response are up-regulated 
(Greene et al., 2005). Furthermore, the phenotype of parkin-deficient flies was 
exacerbated by loss-of-function alleles in genes that limit oxidative damage, 
such as glutathione S-transferase S1 (GstS1), thioredoxin (Trx) and Rlu-A1, 
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which is involved in the synthesis of the anti-oxidant vitamin B2 (Greene et 
al., 2005). Conversely, increased glutathione S-transferase activity rescued 
neuron loss in a different line of parkin mutant flies (Whitworth et al., 2005). 
Finally, our own studies described here corroborate that oxidative stress is 
responsible for the reduced longevity of park25/25 flies. Both N-
acetylcysteine and ascorbic acid (vitamin C) supplementation significantly 
increased the lifespan of park25/25 flies. In addition, overexpression of SOD1 
using the mesoderm-specific driver twi-GAL4 dramatically prolonged the 
survival of parkin mutant flies, possibly by enhancing SOD1 expression in 
muscle tissue, which was affected by apoptotic degeneration in park25/25 flies 
(Greene et al., 2003). Combining N-acetyl cysteine with metal chelators 
extended the maximum but not the median lifespan of park25/25 flies, 
suggesting that metal sequestration extends lifespan, at least in part, by 
reducing oxidative stress. This is consistent with the ability of the iron- and 
copper-chelating agents to reduce ROS levels in the brain of parkin-deficient 
flies (Fig. 3D). 
 
            Recent evidence has placed Parkin in a common pathway with PINK1 in the 
maintenance of mitochondrial function and integrity ([Clark et al., 2006], 
[Park et al., 2006] and [Yang et al., 2006]). Mitochondrial dysfunction and, in 
Drosophila, degeneration have been observed in the absence of either protein 
(Bueler, 2009). However, a unique feature of Parkin is its ability to associate 
with dysfunctional mitochondria and promote their degradation through 
mitophagy (Narendra et al., 2008), suggesting that impaired removal of 
defective mitochondria in the absence of Parkin is pathogenic (Narendra et al., 
2009). As a consequence, endogenous and exogenous factors that impose 
additional stress on mitochondria may result in further accumulation of 
dysfunctional organelles in Parkin-deficient cells, which could increase 
toxicity. Both rotenone and MPP+ are potent inhibitors of mitochondrial 
complex I. In addition, iron is an essential component of many mitochondrial 
proteins (iron–sulfur cluster proteins) that are readily oxidized, and copper-
mediated oxidative stress has been linked to mitochondrial dysfunction in 
neurodegenerative disorders associated with copper imbalance (Rossi et al., 
2004). In line with this, treatment of dopaminergic neurons with copper led to 
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mitochondrial dysfunction, decreased dopamine content and cell death (Shi et 
al., 2008). Thus, the various toxins and metals tested in this study may further 
accelerate and enhance mitochondrial dysfunction and degeneration, 
overwhelming the mitophagy system that is already compromised in parkin-
deficient flies. To study whether chelator treatment mitigated mitochondrial 
degeneration in park25/25 flies, we examined mitochondrial morphology in 
sections of the indirect flight muscles by electron microscopy. However, we 
failed to detect a rescue of swollen mitochondria with disintegrated cristae 
after chelator treatment (data not shown), showing that the life-extending 
effect of metal chelation is likely not due to improved mitochondrial structure, 
but rather due to reduction of oxidative stress that may occur downstream of 
mitochondrial dysfunction in park25/25 Drosophila. In this context, it is worth 
mentioning that food supplementation with zinc, a non-redox-active metal that 
under most conditions functions as an antioxidant, exerts a beneficial effect on 
parkin mutant flies (Saini and Schaffner, 2010). Future studies with flies 
expressing mitochondrial-targeted GFP (Hollenbeck and Saxton, 2005) may 
be interesting to investigate whether metal chelators can improve other aspects 
of mitochondrial biology, such as transport and dynamics, in parkin mutants. 
 
            Finally, our studies show that park25/25 flies are more sensitive to hypoxia 
and heat shock. Interestingly, the three recessive PD proteins Parkin, PINK1 
and DJ-1 associate to form a functional E3 ligase complex (PPD complex) that 
promotes the degradation of Parkin substrates as well as unfolded and 
misfolded proteins after heat shock (Xiong et al., 2009). This strongly 
suggests that the drastically reduced survival of park25/25 flies after heat 
shock is due to impaired removal of misfolded and aggregated proteins that 
may accumulate under these conditions. 
 
            Our studies may have therapeutic implications. The extension of lifespan in 
park25/25 flies by a combination of different metal-chelating agents hints 
towards a possible strategy of reducing oxidative stress in familial PD, where 
carriers of PARK2 (Parkin) mutations could be identified by genetic screening 
and treatment may be administered early to inhibit or delay dopamine neuron 
death. PARK2 mutations are by far the most common in recessive 
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Parkinsonism ([Abbas et al., 1999] and [Gasser, 2005]), accounting for 49–
63% of early-onset familial cases ([Lohmann et al., 2003] and [Lucking et al., 
2000]). In addition, PARK2 mutations are found in 19% of isolated PD cases 
with onset before 55 years ([Lohmann et al., 2003] and [Periquet et al., 2003]). 
Thus, metal sequestration might benefit a significant number of patients. A 
previous study showed that the orally administered iron chelator clioquinol 
was well tolerated in mice, where it resulted in a partial protection against 
MPTP-induced dopamine neuron degeneration in a model of sporadic PD 
(Kaur et al., 2003). Our experiments did not directly address whether 
chelators, in addition to reducing ROS, rescued muscle cell apoptosis (Greene 
et al., 2003) or non-dopaminergic neuronal cell loss that might occur in the 
brain of parkin-deficient flies. Such studies will be important in the future to 
refine the mechanisms of metal chelator-mediated lifespan extension in parkin 
mutant flies. In addition, studies in “familial PD mice” that show frank 
dopamine neuron loss (Lu et al., 2009) will be necessary to test whether metal 
chelation indeed protects against dopamine neuron death caused by Parkin 
mutations. 
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Parkin mutant in the fly is largely rescued by metal-responsive 
transcription factor (MTF-1) 
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Abstract 
 
The gene for Parkin, an E3 ubiquitin ligase, is mutated in some familial 
forms of Parkinson’s disease, a severe neurodegenerative disorder. A 
homozygous mutant of the Drosophila ortholog of human parkin is 
viable but results in severe motoric impairment including an inability to 
fly, female and male sterility, and a decreased lifespan. Here we show 
that a double mutant of the genes for Parkin and the metal-responsive 
transcription factor MTF-1 is not viable. MTF-1, which is conserved 
from insects to mammals, is a key regulator of heavy metal homeostasis 
and detoxification and plays additional roles in other stress conditions, 
notably oxidative stress. In contrast to the synthetic lethality of the double 
mutant, elevated expression of MTF-1 dramatically ameliorates the 
parkin mutant phenotype, as evidenced by prolonged lifespan, motoric 
improvement including short flight episodes, and female fertility. At the 
cellular level, muscle and mitochondrial structures are substantially 
improved. A beneficial effect is also seen with a transgene encoding 
human MTF-1. We propose that Parkin and MTF-1 provide 
complementary functions in metal homeostasis, oxidative stress and other 
cellular stress responses. 
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Abstract 
 
The gene for Parkin, an E3 ubiquitin ligase, is mutated in some familial forms of 
Parkinson’s disease, a severe neurodegenerative disorder. A homozygous mutant of 
the Drosophila ortholog of human parkin is viable but results in severe motoric 
impairment including an inability to fly, female and male sterility, and a decreased 
lifespan. Here we show that a double mutant of the genes for Parkin and the metal-
responsive transcription factor MTF-1 is not viable. MTF-1, which is conserved from 
insects to mammals, is a key regulator of heavy metal homeostasis and detoxification 
and plays additional roles in other stress conditions, notably oxidative stress. In 
contrast to the synthetic lethality of the double mutant, elevated expression of MTF-1 
dramatically ameliorates the parkin mutant phenotype, as evidenced by prolonged 
lifespan, motoric improvement including short flight episodes, and female fertility. At 
the cellular level, muscle and mitochondrial structures are substantially improved. A 
beneficial effect is also seen with a transgene encoding human MTF-1. We propose 
that Parkin and MTF-1 provide complementary functions in metal homeostasis, 
oxidative stress and other cellular stress responses. 
 
Keywords: Drosophila/ MTF-1/ metal homeostasis/ parkin/ Parkinson’s disease 
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Introduction 
 
Parkinson’s disease (hereafter referred to as PD) is the second most prevalent 
progressive neurodegenerative disorder and the most common age-related movement 
disorder (10, 13, 43, 59). Many molecular aspects of PD pathogenesis still need to be 
clarified. Extensive studies point to oxidative stress as a major contributor to the 
disease (28). Besides the gene for Parkin, an E3 ubiquitin ligase, four other genes: 
PINK1, DJ1, UCHL1 and α-synuclein have been implicated in rare, early-onset, 
familial forms of PD while LRRK2 is predominantly responsible for late onset PD 
(20, 57, 70). Much effort has gone into the development of animal models of PD, 
including models in the fly Drosophila melanogaster. In our studies presented here, 
we use a strain in which the ortholog of the human parkin gene has been disrupted by 
insertion of a P-element transposon into the coding region (24, 48). 
 
In mammals, the proteins PINK1 and Parkin cooperate to ensure proper quality 
control of mitochondria and Parkin is particularly important for autophagy of faulty 
mitochondria (reviewed in (8, 73). In agreement with this notion, Parkin deficient 
flies suffer from mitochondrial malfunction (24, 45, 48), which distorts muscle 
structure and causes severe locomotor defects and an inability to fly (24, 48).  
Furthermore, both male and female parkin null mutant Drosophila are sterile (52), 
exhibit an increased sensitivity to multiple stresses, including oxidative stress, and 
have a reduced lifespan (23, 48).  
 
Maintenance of metal homeostasis is an essential requirement for the proper 
functioning of all organisms. An adequate supply of essential trace metals, like copper 
and zinc, is important, whereas an excess can be highly toxic. Alterations in copper 
homeostasis due to mutations in copper transporters cause Wilson’s and Menkes 
disease (11, 31, 65). An imbalance in trace metal levels has also been implicated in 
neurodegenerative disorders such as Parkinson’s and Alzheimer’s disease, as well as 
in senescence processes (42, 53, 54). To investigate the possible interplay of Parkin 
function with metal homeostasis, we modulated the concentration of the metal 
responsive transcription factor-1 (MTF-1) in parkin mutant Drosophila. MTF-1 is 
conserved in evolution and its homologs have been characterized in humans (7, 36, 
44), mice (25, 51, 69), fish (3, 9) and Drosophila (17, 60, 75). MTF-1, also referred to 
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as metal response element binding transcription factor 1, is a zinc-finger protein that 
regulates transcription of its target genes by binding to DNA sequence motifs known 
as metal response elements (MREs), which are typically located proximal to the 
transcription start (12, 27, 32, 41, 64, 68). The majority of MTF-1 preferentially 
localizes to the cytoplasm in quiescent, non-stressed cells but translocates to the 
nucleus upon heavy metal load and a number of other stressful conditions (34, 58, 
62).  
 
Apart from counteracting the effects of heavy metal load, MTF-1 also induces 
transcription of metallothionein genes in response to oxidative stress and infection (2, 
21, 22). Metallothioneins (MTs), are small, cysteine-rich, metal-binding proteins with 
a major role in metal homeostasis and detoxification (30, 46). MTs occur in all 
eukaryotes, as well as in some prokaryotes. Heavy metals like zinc, copper and 
cadmium are complexed by the cysteine sulfhydryl groups, which can also exert 
antioxidant function (2, 29). In this context it is noteworthy that in a mouse PD 
model, dopaminergic (DA) neurons of a MT-knockout mutant are more vulnerable to 
L-DOPA toxicity than neurons from mice with wild type MT (15, 39). This suggests 
that MTs play a protective role against DA-quinone induced neurotoxicity. There are 
more than ten functional metallothionein genes in humans, four in the mouse (50, 71) 
and at least four in Drosophila, termed MtnA-MtnD  (17, 40). The Drosophila MTs 
are involved to different degrees in the defense against heavy metal stress. MtnA is 
the most important under copper load, while MtnB preferentially binds cadmium and 
protects against cadmium intoxication. MtnC and MtnD, despite sharing 67% amino 
acid identity with MtnB, have only a minor role in protection against heavy metals, at 
least when MtnA and MtnB are present (16, 18). The MtnA and MtnB genes (also 
referred to as Mtn and Mto, respectively) are differentially regulated during 
development (61). In addition to metallothioneins, MTF-1 also regulates, in 
Drosophila, the expression of ferritins, the copper importer Ctr1B, the zinc exporter 
ZnT35C, glutathione S-transferase and an ABC transporter (60, 63, 74). 
 
MTF-1 proteins of human and Drosophila are highly similar in their DNA-binding 
zinc finger region but quite divergent outside of it. Nevertheless, they can largely 
complement each other in the protection against metal stress (6, 75). A major 
difference between mammals and Drosophila is that metallothionein genes in 
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mammals are mainly induced by zinc and cadmium whereas in Drosophila they are 
best induced by copper and cadmium (18, 75, 76). Moreover, disruption of the MTF-1 
gene in the mouse results in embryonic lethality (25), which is not the case for fly 
mutants, which are viable and fertile. However, the fly mutants do display sensitivity 
to cadmium, zinc and copper load as manifested by a reduced lifespan on heavy-metal 
supplemented food, and also cannot tolerate copper starvation (17, 60). The 
Drosophila allele MTF-1140-1R carrying a 4.1 kb deletion of the coding region has the 
strongest phenotype and is considered a null mutation (17). We have used this allele 
for experiments requiring a MTF-1 loss of function.  
 
A link between cellular heavy metal handling and the parkin mutant phenotype was 
suggested by our previous finding of a partial rescue of parkin mutant flies upon zinc 
supplementation or chelation of redox-active metals (55, 56). In our present study we 
set out to investigate the interaction between metal homeostasis and Parkin function, 
or more specifically, MTF-1 and Parkin. We found that parkin mutants combined 
with a knockout of MTF-1 are not viable, a genetic constellation termed synthetic 
lethality. Parkin mutant Drosophila suffer from oxidative stress as a result of 
heightened ROS production. A strong ubiquitous MTF-1 expression dramatically 
ameliorates the parkin mutant phenotype: our results show that MTF-1 decreases 
oxidative stress, normalizes concentration of essential trace metals, increases the 
frequency of development to adulthood, restores female fertility, improves 
muscle/mitochondrial morphology, locomotion and considerably extends the lifespan 
of parkin mutant flies.  
 
Materials and Methods 
 
Fly food and maintenance 
One liter of standard fly food was composed of 55 g cornmeal, 10 g wheat flour, 100 
g yeast, 75 g glucose, 8 g agar and 15 ml anti-fungal agent Nipagin (15% in ethanol). 
For the experiments of survival, development, eclosure frequency, ROS 
measurements, real-time PCR and TEM muscle analysis, several conditions were 
tested, namely, normal food (NF), NF supplemented with zinc chloride (4 mM) or N-
acetylcysteine (15 mM) or bathocuproine disulfonate (BCS, copper chelator) (0.3 
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mM), and bathophenanthroline sulfonated sodium salt (BPS, iron (copper) chelator) 
(0.1 mM). All flies were maintained at 25oC on a 12:12 hours light-dark cycle. 
 
Construction of transgenic flies and fly stocks 
UAS-MTF-1 flies were generated using the full-length MTF-1 cDNA cloned into the 
pUAST vector. Tub-MTF-1 constructs were made by cloning the MTF-1 cDNA under 
the control of the constitutive α–tubulin promoter. Both the constructs were injected 
into the w1118 fly strain along with p(∆2-3) helper plasmid and transformants were 
selected based on the eye color (red/orange). The MTF-1140-1R null allele, generated by 
homologous recombination, was characterized previously (17). The UAS-MTF-1, MT 
(tub-MtnA), MTF-1140-1R strains were generated by recombination in our laboratory. 
The w; +; tub-MtnA/TM6B (tub-MtnA), w; tub-MTF-1/Cyo;+ (tub-MTF-1) and 
w;Actin-Gal4;UAS-MTF-1/TM6B (Actin-Gal4;UAS-MTF-1) flies were combined 
with w;+;park25/25 (park25/25) by recombination. Unless specified otherwise, 
w;+;park25/TM6B,w+ flies (heterozygous parkin mutants hereafter referred to as 
park25/+) were used as controls for the w;+;park25/25  flies (homozygous parkin 
mutants hereafter referred to as park25/25). park25/25 is a null mutation of the 
Drosophila parkin gene (24). The TM6B balancer in the control flies was confirmed 
to have no effect on any of the experiments performed (by removing it). 
 
Lifespan determinations, eclosure frequency and fertility assays 
For lifespan experiments, 1-2 day old flies (20 per vial) maintained at 25oC on a 12:12 
hours light-dark cycle were examined for each genotype at least in triplicate. 
Surviving flies were transferred to fresh food vials every 2 days and counted daily. In 
the experiment with w;Actin-Gal4;UAS-MTF-1, park 25/TM6B flies, the survivors in 
23 parallel independent sets were counted at regular time intervals. In each lifespan 
assay testing different conditions, the controls of park25/+ and park25/25  flies raised on 
NF were the same. The variations in the average lifespan of control flies in different 
experiments can be attributed to subtle experimental variations. The metal chelator 
concentrations selected for ROS determination had no significant effect on feeding 
behavior of the flies (55). Fertility was assayed by placing single parkin mutant males 
with 3-4 virgin yw females and by placing single virgin parkin mutant females with 
two yw males. Vials were checked 3-7 days later for the presence of larvae and 
eclosing adults. For the analysis of eclosure frequency, the number of days allowed 
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for egg laying and the parent population was the same in all vials of normal food (NF) 
or zinc (Zn)-supplemented food and progeny flies were counted at the same time. 
 
Behavioral assay (climbing performance and locomotion ability) 
The Climbing assay was performed as described (47). Flies of each genotype 
(park25/+, park25/25, tub-MTF-1,park25/+, tub-MTF-1, park25/25) were anesthetized with 
CO2 and individually counted and placed in food vials 24 hours before the assays 
were performed to enable a full recovery from the effects of CO2. Ten flies were 
placed in an empty 110-by 27-mm vial; a horizontal line was drawn 100 mm above 
the bottom of the vial and another identical vial was used as a cover to provide more 
mobile space. After the flies had acclimated for 10 min at room temperature, each 
genotype was assayed in triplicate for five trials per set per genotype. The procedure 
involved gently tapping the flies (on a soft surface) down to the bottom of the vial. 
The flies were given 30 seconds to climb the vial and the number of flies which 
crossed the 100 mm mark each time were recorded. These values were then averaged 
and a group mean and standard error was calculated. The mean values of various fly 
groups were statistically compared using an unpaired Student t-test. The study was 
repeatedly performed with the same group of flies on every alternate day up to 10 
days in an isolation room at 25oC, 60-70% humidity under standard lighting 
conditions. Preliminary studies indicated no significant difference in the outcome of 
climbing assays performed in normal light or red light conditions. 
 
Fluorescent protein (EYFP) reporter 
The Drosophila metallothionein MtnA promoter (-446 to +74) was cloned from 
genomic DNA using the primer pair 5’-CGG GAT CCA GGT ATG GGC TAT TTA 
GGC C-3’ and 5’-GGG ATG GCC CCA AAG GAT CTG-3’ in a pCasper4-derived 
vector carrying EYFP-coding sequence and the SV40 polyA site. Details were 
reported previously (6, 18). Transgenics of MtnA-EYFP combined with parkin 
heterozygous or homozygous knockouts were made. Both fly types were then frozen 
at the same age and photographs of EYFP expression were taken with a Leica MZ 
FLIII fluorescence stereomicroscope and a Nikon Coolpix 950 digital camera (Leica, 
Heidelberg, Germany) at an exposure of 730 ms. 
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RNA isolation and real-time analysis 
Total RNA was purified from adult Drosophila tissue using the Nucleospin RNA II 
protocol (Macherey-Nagel) and eluted in 60 µl of RNase-free water. cDNA was 
prepared using the Transcriptor High Fidelity cDNA Synthesis kit from Roche. The 
cDNA obtained was further purified using the AM 1906 Ambion DNA free kit and 
used for analysis by real-time PCR on the Tecan Genesis 200/8 robot using the 
Eurogenentec Mesa Green qPCR Mastermix Plus for SYBR assays. The qPCR run 
was performed on an Applied Biosystem machine (ABI Prism SDS 7900 HT) in a 
384 well format with a reaction volume of 10 µl. ΔΔct values were calculated by 
subtracting the Δct calibrator from the Δct sample, Δct values were calculated by 
subtracting Δct endogenous control from Δct target gene/calibrator. The normalization 
strategy used has been described in Vandesompele et al (67). All the fold-change 
values are normalized to respective park25/+ values on normal food (NF). The 
housekeeping genes used were actin5c, TBP and GAPDH. Two sets of primer 
sequences were used for each of the transcripts quantified: for parkin, the first primer 
set was 5’-AAG ATC ATA TTT GCC GGT AAG GAA-3’ and 5’-CGC TTT GCT 
GAC CCA AGT C-3’ which amplify a 73 bp fragment only from the parkin 
heterozygous control flies and the second set was 5’-CAA AGC CCT GTC CAA 
AAT GC-3’ and 5’-GCG CGT GTG CAG ACC AT-3’; for MTF-1, the first primer 
set was 5’-TGT CCG GCT GCG ATA AGG-3’ and 5’-GCC ATT GTG CAG ACG 
AAG GT-3’ which amplify a 68 bp fragment from wild-type MTF-1 containing flies 
and the second set was GCA TTC AAC ACG CGC TAC A-3’ and 5’-ACA GTT 
GAA CGT CTC GCC ATT-3’; for MtnB, the first primer set was 5’-TTG CAA GGG 
TTG TGG AAC AAA-3’ and 5’-TGC AGG CGC AGT TGT CC-3’ which amplify a 
65 bp fragment and the second set was 5’-AAG TCG AGA AAT AGA TAC ATA 
CAA GAT GGT-3’ and 5’-CGC ACT TTT GGG CCG AG-3’; for foi, the first primer 
set was 5’-GTG GCT GCG GGT CTG TTC-3’ and 5’-TTT GTG CGA GGC CGA 
GAT-3’ which amplify a 69 bp fragment and the second set was 5’-TGG CGA TGC 
CCT ACT TCA C-3’ and 5’-TGA TCA TCC CCC GCT CAT-3’.  
 
Detection of ROS levels 
Fresh dichlorofluorescin diacetate (2,7-DCFH-DA) from Invitrogen – Molecular 
Probes Cat # C369 was mixed with DMSO to make a 1 mM stock solution (=2,7-
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DCFH-DA/DMSO). A 40 µM working solution was prepared in HEPES buffer (30 
mM). 50 heads of frozen adult flies of a specific genotype (same age) were removed 
and collected in an Eppendorf tube. This was done in triplicate for each condition. 
Each sample was then homogenized using cold protein homogenization buffer (1:3 
w/v of 0.32 mM sucrose, 20 mM HEPES, 1 mM MgCl2, 0.5 mM PMSF protease 
inhibitor at pH 7.4) and centrifuged for 20 minutes at 4oC and 20,000 g. Protein 
content of the supernatant was determined using the Bio Rad diagnostics kit and a 
final concentration of 0.4 mg/ml was used as the standard for the ROS assay of each 
genotype tested. The fluorescence intensity (emission acquisition) was monitored for 
45 minutes after the sample (20 µl) was kept in a cuvette (1.5 x 1.5 nm) in the 
fluorimeter immediately after the addition of the DCFH-DA dye (2 µl) to prevent loss 
of signal due to fading of fluorescence. Excitation of dye was at 485 nm and emission 
at 520 nm. The curve area of fluorescence intensity which was recorded every 5 
minutes (for 45 minutes) in the range of 500-600 nm was integrated and the total area 
was used for comparison, with the final result obtained in counts per second. The 
fluorimeter was standardized using 0.05% H2O2, a positive ROS generating species.  
 
Dissection of ovaries 
Ovaries from female parents were dissected in Grace’s insect medium (1X), GIBCO, 
Invitrogen at room temperature (RT). The dissected ovaries were immediately fixed 
in 4% paraformaldehyde, 0.2% Triton-X-100 dissolved in Grace’s medium for 20 
minutes without shaking, The fixative was washed three times with phosphate buffer 
saline (PBS)+0.5% Triton (PBST) for 10 minutes each. The samples were then 
labeled for one hour with fluorescently labeled phalloidin (Phalloidin-alexa 568, 
molecular probes), diluted 1:200 in PBST at RT. This was followed by three washes 
with PBST for 10 minutes each and a second labeling with Toto (nuclear stain) 
diluted 1:1000 in PBST at RT. The samples were then washed three times with PBST 
for 10 minutes each, followed by two washes with PBS for 10 minutes each and then 
embedded in vectashield (mounting medium) overnight at -20oC. Ovarioles were 
dissected from the ovaries and mounted on glass slides. Pictures were taken using the 
confocal at 20X magnification. 
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Quantification of metal content 
Female flies (park25/+, tub-MTF-1, park25/+ and yw and MTF-1 knockout controls) 
were allowed to lay eggs on normal food or metal-supplemented food (100 µM 
cadmium sulphate/ 500 µM copper sulphate/ 500 µM ammonium ferric citrate/ 4 mM 
zinc chloride) for four days and removed afterwards. The resulting progeny were 
collected at regular intervals and frozen. This procedure was repeated until the 
required number of 50 flies was obtained in triplicate for each genotype. Each sample 
set of frozen flies was then subjected to homogenization using cold protein 
homogenization buffer (0.32 mM sucrose, 20 mM HEPES, 1 mM MgCl2, 0.5 mM 
PMSF protease inhibitor at pH 7.4) and the samples were normalized for protein 
content. A final concentration of 1 mg/ml was prepared by diluting the samples in 
0.2M HNO3 to obtain a total assay volume of 1 ml. A highly sensitivity flame atomic 
absorption spectrophotometer (FAAS; GTA-120/PSD-120, Varian Australia Pty Ltd, 
Mulgrave, VIC, Australia) was used to detect the metal content in each genotype 
assessed. Cd and Zn concentrations were recorded by the same flame. Likewise Cu 
and Fe concentrations were measured together. 
 
Muscle section and TEM  
Dissected thoraces of two-day old anesthetized adult flies (park25/+, park25/25 and Act-
Gal4; UAS-MTF-1,park25/25) were kept in ice-cold fixative (2.5% glutaraldehyde/0.1 
M sodium cacodylate buffer adjusted to 328 mOsm/l with sucrose, pH 7.4) for 4 
hours at 4°C. Postfixation was performed with 1% OsO4 and 0.1 M sodium 
cacodylate, pH 7.4 for 2 hours at 4°C and the sample was washed overnight with 0.1 
M sodium cacodylate, pH 7.4 before going through a series of progressive 
dehydration steps in a graded ethanol series of 70/80/96% alcohol for 10 minutes 
each, followed by three 10 min washes in 100% alcohol and a final 20 min wash in 
propylene oxide. The sample was treated with a 1:1 propylene oxide: Epon (Epon 
812) mix for 2 hours and embedded in Epon overnight at 70oC. Blocks of thoraces 
were trimmed and semi-thin sections of dorsal longitudinal muscles were stained with 
Toluidine Blue dye, which labels nucleic acids, hence staining both nuclei and 
cytoplasm (5). Ultrathin sections of 70 nm thickness were made with an 
ultramicrotome for the selected sections. For TEM, sections were contrast-stained on 
the grid first with 2% uranyl acetate, then with 2.5% lead citrate (Reynold’s), each of 
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them for twenty minutes at room temperature. The sections were inspected with a 
Philips CM100 TEM with GATAN Orius Camera.  
 
Statistical Analysis 
JMP software (SAS Institute) was used for statistical evaluations. Lifespan (survival) 
assays were analyzed with the Kaplan–Meier log-rank statistical test. Brain ROS 
levels and qPCR results were compared by one-way ANOVA. Results are expressed 
as mean ± standard deviation.  
 
Results 
 
Synthetic lethality of combined parkin and MTF-1 mutants 
 
The metal-responsive transcription factor (MTF-1) is a key regulator of metal 
homeostasis in Drosophila (17, 60, 75). Based on our findings of a connection 
between the parkin knockout and trace metal status (55), we tested the effect of an 
MTF-1 knockout in a parkin mutant background. The result was clear cut, in that no 
surviving double mutant was ever observed in 50 independent crosses. This “synthetic 
lethality,” observed at the pupal stage, was rescued by a cDNA transgene of MTF-1 
driven by the constitutive tubulin enhancer/promoter. In a genetic cross between 
parents heterozygous for the parkin and MTF-1 recombined deletions (Figure 1), 69 
out of a total of 217 progeny (32%) were parkin and MTF-1 homozygous knockouts 
also expressing an MTF-1 transgene (statistical expectation, 40%). This rescue by an 
MTF-1 cDNA transgene confirms the absence of any secondary hits as the cause of 
the observed lethality. Furthermore, it also excludes the possibility that an intronic 
open reading frame located within the MTF-1 gene (D. Steiger, K. Steiner and WS, 
unpublished) is responsible for the effect and not MTF-1 itself. To find out what 
condition could overcome the pupal lethality, we maintained the heterozygous parkin, 
MTF-1 parent flies on N-acetylcysteine (NAC), which is a precursor to glutathione, 
an established antioxidant. Since either condition, lack of a functional parkin gene or 
of an MTF-1 gene, increases reactive oxygen species (ROS) (see below), we reasoned 
that keeping a lower ROS level by other means might also overcome the synthetic 
lethality of the double mutants. After testing different concentrations of NAC an 
optimal supplement of 15 mM was chosen for the main experiment. Indeed, raising 
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the progeny under this condition resulted in a substantial rescue of the synthetic 
lethality: of the total progeny, 19% was homozygous parkin and MTF-1 double 
mutant (statistical expectation, 25%) (Table 1A). Other antioxidants tested included 
ascorbate, zinc, and metal chelators of copper and iron (BCS and BPS, respectively) 
which we had shown before to positively influence the parkin mutant phenotype (55, 
56). However, none of these was able to rescue synthetic lethality. 
 
MTF-1 overexpression rescues the lifespan and the low eclosing frequency of 
parkin mutants 
 
We examined the lifespan of Drosophila MTF-1-overexpressing transgenic lines (tub-
MTF-1 and Act-Gal4; UAS-MTF-1) in a  park25/25 background. These experiments 
illustrated that an elevated expression of MTF-1 from the ubiquitously active tubulin 
enhancer/promoter prolonged the lifespan of parkin mutants significantly, from a 
median of 7 days for the mutants alone to 21 days (Figure 2A). In this experiment, the 
maximal lifespan was extended from 12 to 41 days by the MTF-1 transgene (Figure 
2A). The stronger combination with actin-Gal4 driving UAS-MTF-1 revealed a 
similar effect: in an experiment with 23 independent replicas, 10% of the mutant 
animals were still alive at day 34 (Figure 2B). Overexpression of MTF-1 in control 
and wild type flies (park25/+ or park+/+) did not increase their normal lifespan (data 
not shown). Also, in an independent study, MTF-1 overexpression did not extend 
lifespan of flies kept on standard food (4). Elevated MTF-1 expression not only 
prolonged the lifespan of parkin mutant adult flies but also enhanced survival during 
development. In a genetic cross involving parkin heterozygous parents, only 2.5% of 
the eclosing progeny flies were homozygous parkin mutants (statistical expectation, 
25%). In comparison, the same cross but also expressing an MTF-1 transgene resulted 
in a 15% eclosure frequency (Table IB). 
 
Elevated expression of MTF-1 rescues female fertility and fecundity of parkin 
mutant flies 
 
Strikingly, female fertility and fecundity was completely rescued by MTF-1. When 
crossed with wild type males, parkin mutant females with the tubulin-driven MTF-1 
transgene produced the same number of progeny as a cross of wild type males and 
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females. Drosophila gonad formation requires a complex morphogenetic process (35, 
37). As in the majority of metazoans, Drosophila oogenesis occurs within the ovarian 
follicles in which germline cells develop in close proximity to specialized somatic 
cells (Figure 3A-A’’). Parkin mutant females lack the proper spatio-temporal 
development in the germarium and thus have stunted ovaries with few mature 
oocytes, which fail to get fertilized (Figure 3B-B’’’). The restoration of female 
fertility by strong MTF-1 expression was also evident at the morphological level: 
dissected ovaries showed a normalized structure with follicles formed in the 
germarium and mature stages in the posterior regions of the ovariole, with several 
oocytes ready for fertilization (Figure 3C-C’’). In contrast, the sterility phenotype of 
parkin mutant males which is due to defective spermatogenesis at the 
individualization step (24) was not rescued. This suggests that Parkin is particularly 
important for male fertility. 
 
Improved locomotion and rescued mitochondrial/myofibrillar morphology of 
parkin mutants with enhanced MTF-1 expression 
 
Strong MTF-1 expression dramatically improved the climbing ability of parkin 
mutant flies (Figure 4). What is more, they generally moved around fast, responded 
by running away when physically perturbed, jumped and occasionally displayed short 
flight episodes (data not shown). To investigate the effect of elevated MTF-1 
expression on muscle morphology we examined the ultrastructure of the indirect 
flight muscle in heterozygous control flies, parkin mutants and the MTF-1 transgenic 
flies. Cross-thoracic sections of control adults analyzed by transmission electron 
microscopy (TEM) revealed well organized muscle fibres in parallel stripes with a 
regular M- and Z-line banding pattern and darkly stained, electron-dense 
mitochondria with regularly packed cristae (Figure 5A-C). In contrast, age-matched 
parkin mutants had abnormal muscle structure with large vacuoles, a reduced muscle 
content with mostly irregular arrangement and enlarged mitochondria with 
disintegrated cristae (Figure 5D-F). The MTF-1 overexpressing parkin mutant flies 
displayed a clear rescue effect in that muscle fibre structure was more regular with 
less prominent vacuoles; moreover, mitochondria had more densely packed cristae 
with considerably lesser signs of disintegration in comparison to parkin mutants 
(Figure 5G-I). 
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MTF-1 dependent expression of metallothioneins is higher in parkin mutant 
Drosophila 
 
Owing to their high cysteine content, metallothioneins can act as antioxidants, in 
addition to their obvious role as metal chelators (33, 38). Basal and induced levels of 
metallothionein expression depend on the transcription factor MTF-1 (17, 51, 74). To 
find out whether metallothionein genes could be induced by MTF-1 in a parkin 
mutant background, we used a reporter line in which a yellow fluorescent protein 
(EYFP) is driven by the promoter of MtnA, the most highly expressed Drosophila 
metallothionein gene. Compared to heterozygous controls, even in the absence of any 
heavy metal load the basal expression of this reporter was increased, likely due to 
elevated oxidative stress in the parkin mutant flies (Figure 6C and D). This metal-
independent upregulation of the MtnA promoter, was strictly dependent on MTF-1, 
since no trace of fluorescence could be detected in flies lacking MTF-1 (data not 
shown). RT-PCR of parkin mutants also revealed elevated transcript levels of MTF-1 
(2-fold) (Figure 7A) and the embryo-enriched metallothionein MtnB (6-fold) (Figure 
7B) compared to park25/+ flies. MTF-1 overexpression in the park25/25 flies was 
achieved from the tubulin promoter or indirectly with the stronger UAS-Act-Gal4 
system, both induced a more than 200-fold increase in MtnB transcripts (Figure 7B). 
Conversely, the level of parkin transcripts was increased in the MTF-1 knockout flies 
(Figure 7C). This pattern of regulation can be explained by a partial redundancy of 
Parkin and MTF-1 where one is upregulated to compensate for the loss of the other. 
The synthetic lethality of a combined knockout of parkin and MTF-1 genes 
mentioned above is in line with this hypothesis. Another experiment revealed that the 
transcript levels of the zinc importer foi (37) in parkin mutants were enhanced 3-fold 
by elevated MTF-1 expression, which may contribute to the normalized structure of 
ovaries and rescued fertility of female parkin mutants (Figure 7D). This hypothesis is 
further supported by the increased level of zinc ions found in tub-MTF-1; park25/25 
flies (discussed below, Figure 8B). 
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Elevated MTF-1 expression confers resistance to oxidative stress and restores 
metal homeostasis 
 
Parkin mutant flies display high levels of ROS indicative of intrinsic oxidative stress 
(23, 72). In agreement with MTF-1 having an antioxidant function, we observed a 
substantial decrease of ROS levels in the heads of parkin mutants expressing an MTF-
1 transgene: ROS dropped to approximately half of the levels in park25/25 flies (Figure 
8A). Previously we had observed that limiting the availability of redox-active metals, 
achieved by supplementing the food with chelators for copper and iron (BCS and 
BPS, respectively), also increased the lifespan of parkin mutant flies (55). 
Furthermore, the w;tub-MTF1;park25/25  flies raised on the metal-chelator-
supplemented food displayed a somewhat lower ROS level (Figure 8A). ROS levels 
were not significantly changed in heterozygous control flies, either upon ubiquitous 
MTF-1 overexpression or following dietary intake of metal-chelators. The MTF-1 
knockout flies showed the highest levels of ROS, probably due to the reduced 
expression of MTF-1-dependent antioxidant genes such as metallothioneins (Figure 
8A). Metals like zinc and the redox active copper and iron are required in trace 
amounts for several structural and biological processes in organisms (66). Park25/25 
flies display not only reduced basal levels of zinc (see also (56)) but also of copper 
and iron in comparison to control flies (Figure 8B). Tubulin-driven MTF-1 expression 
in park25/25 restores the basal level of these metals (Figure 8B). Concentrations of 
cadmium are generally low since it is a non-essential, toxic metal. Upon 
supplementing fly food with metals, their levels became quite similar in all three 
genotypes tested (Figure 8C). This is particularly important in the case of zinc 
supplementation, which we had previously shown to improve the condition of parkin 
mutant Drosophila (56). 
 
Human MTF-1 or elevated metallothionein expression also improve condition of 
parkin mutants 
 
Human MTF-1 has been expressed in Drosophila and shown to largely, but not 
completely, rescue the metal sensitivity of Drosophila lacking its endogenous MTF-1 
(6). We therefore tested the effect of actin-Gal4-driven hMTF-1 expression in a 
parkin mutant background. Indeed the lifespan of parkin mutants was increased from 
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a median of 7 days to 19 days, which is close to the 21 days obtained with elevated 
Drosophila-MTF-1 expression (Figure 9). Other rescue effects paralleled those 
observed with elevated Drosophila MTF-1 expression (see above) but were less 
pronounced (data not shown). 
 
Metallothionein genes are the major targets of MTF-1; in Drosophila, metallothionein 
A (MtnA) shows the strongest expression. Thus, we also tested if overexpression of 
MtnA in a parkin mutant background exerted a similar beneficial effect as MTF-1 
overexpression. To this end we crossed inter se three independent lines with tubulin-
driven MtnA overexpression in a parkin heterozygous background to raise parkin 
homozygous knockouts. The median lifespan of the parkin mutants was extended up 
to 17 days (Figure 9) but other rescue effects associated with elevated MTF-1 
expression (discussed in results) were not observed. 
 
Discussion 
 
Here we show that metal responsive transcription factor (MTF-1) plays a crucial role 
in modulating the severity of a Parkin loss-of-function phenotype. On the one hand, 
the combined loss of Parkin and MTF-1 is not viable, i.e., displays synthetic lethality. 
On the other hand, elevated expression of MTF-1 dramatically improves the condition 
of parkin mutant flies: there is an overall extension of life span, females regain 
normal fertility, and the motoric abilities of flies improve to the point that they can 
walk fast and even display short episodes of flight. The latter is noteworthy since 
flight muscles have a high energy consumption that depends on robust mitochondrial 
function. At the histological level, the degenerated mitochondria characteristically 
seen in parkin mutants are rescued to a more regular, electron-dense structure 
following MTF-1 overexpression. Additionally, flight muscles have an improved 
myofibrillar arrangement. In earlier studies, mitochondrial and muscle degeneration 
observed in parkin mutant flies were proposed to be a result of excessive oxidative 
stress (24, 48). Mitochondrial malfunction can indeed result in an increased 
susceptibility to oxygen radical damage, and mitochondria-associated increase in 
ROS production has been implicated in Parkinson’s disease (19, 26, 73). In line with 
this concept, the major target genes of MTF-1 are metallothioneins (MTs), which 
encode small, cysteine-rich proteins that can scavenge heavy metals, notably the 
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redox-active copper, and ROS. The elevated basal level of MTF-1 and MT transcripts 
in parkin mutant flies can thus be seen as a compensatory attempt to counteract 
enhanced ROS levels (24). In accordance with such a scenario is the rescue effect 
seen upon food supplementation with the antioxidant N-acetylcysteine, which 
however falls short of the dramatic effect seen with elevated MTF-1 expression. 
Besides metallothioneins and a number of other stress-associated genes, ferritin genes 
are a major target of MTF-1 in Drosophila (74). Ferritins are well-characterized iron 
binding proteins which keep iron in a soluble and non-toxic form in the cell. Thus 
ROS production by redox-active iron might be lowered via upregulation of ferritin 
levels. The multiple targets of MTF-1 help to explain why overexpression of 
metallothionein alone was less effective than MTF-1 overexpression in improving the 
condition of parkin mutants. In a separate series of experiments we found that strong 
expression of an ortholog, the human MTF-1, also increased lifespan, rescued female 
fertility and improved locomotion ability, although the effects were less pronounced 
than with Drosophila’s own MTF-1, presumably due to the evolutionary distance 
between mammals and insects. This is in line with previous findings from our 
laboratory that mammalian and Drosophila MTF-1 transgenes are able to largely, but 
not completely, compensate for each other’s absence (6). 
 
Although we observed remarkable improvements following elevated MTF-1 
expression, a complete rescue of parkin mutants, including male fertility and 
sustained flight ability, was only observed with a parkin transgene. Furthermore, it 
has to be pointed out that although MTF-1 knockout flies display high ROS levels, 
they show no signs of Parkinson’s disease-like symptoms. Together these findings are 
consistent with the idea that oxidative stress is an important but not the sole culprit in 
PD etiology (1, 14, 49). Nevertheless, the dramatic effect of MTF-1 on a parkin loss-
of-function mutation underscores the importance of this transcriptional regulator in 
cellular stress response. 
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Figure Legends  
 
Figure 1. Scheme of genetic cross to obtain strong MTF-1 expression in double 
mutant background. An MTF-1 cDNA transgene driven by the tubulin promoter 
was combined with homozygous null mutations of both MTF-1 (MTF-1-) (17) and 
parkin (park25) (24); progeny in red. The Sp marker on the second chromosome gives 
a uniform-length side-bristle phenotype and the CyO second chromosome balancer 
results in curly wings. TM3 and TM6B are third chromosome balancers which display 
a serrated wing phenotype and a dense side bristle phenotype, respectively. Balancers 
are lethal in homozygous form; progeny marked with a cross indicate lethality of that 
particular genotype. Chromosome 1 is wild type. 
 
Figure 2. Enhanced lifespan of parkin mutants expressing an MTF-1 transgene. 
(A) A cDNA transgene of Drosophila-MTF-1 driven by the ubiquitously active 
tubulin enhancer/promoter prolongs the lifespan of parkin mutants (park25/25) up to 41 
days. For survival of park25/25 vs. tub-MTF-1, park25/25 flies, p<0.001. (B) Strong 
expression of a UAS-MTF-1 transgene driven by actin-Gal4 in a parkin mutant 
background also extends  lifespan, as tested in multiple sets of Act-Gal4; UAS-MTF-
1, park25/25 flies. In both (A) and (B), heterozygous park25/+ flies with MTF-1 
overexpression had a similar lifespan as park25/+ controls (data not shown). 
 
Figure 3. Elevated MTF-1 expression restores ovary structures and restores 
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fertility of parkin mutant females. (A-A’’) Normal ovariole structures of fertile 
control female flies (park25/+). (B-B’’’) Infertile female parkin mutants (park25/25) 
have a distorted ovary structure with very few mature eggs. (C-C’’) Upon expression 
of a tubulin-driven MTF-1 transgene ovary structures are normalised, resulting in 
normal fertility. a, anterior with germarium; p, posterior with vitellarium; broken 
arrows indicate mature eggs; full arrows developing stages of eggs. Phalloidin (red) 
stains tubulin structures and Toto (blue) stains the nuclei. 
 
Figure 4. MTF-1 transgene expression restores the climbing ability of parkin 
mutants. Tubulin enhancer/promoter-driven MTF-1 expression largely rescues the 
locomotion ability of park25/25 flies. In control flies, MTF-1 overexpression does not 
further improve climbing ability. Data shown represents mean value ± standard 
deviation of each group tested every other day up to 8 days. Asterisks show highly 
significant differences between parkin control (park25/+) and parkin mutant (park25/25) 
flies on each day of the assay (p< 0.0001).  
 
Figure 5. Strong MTF-1 expression improves muscle and mitochondrial 
morphology of parkin mutants. (A-C) Transverse sections of indirect flight muscles 
(IFMs) show well preserved muscle in park25/+ heterozygous controls with a regular 
myofibril arrangement (white arrows) and many electron-dense mitochondria (broken 
red arrows). (D-F) park25/25 adult IFMs show an irregular myofibrillar arrangement 
with diffuse Z-lines and M-bands and numerous vacuoles. Mitochondria are swollen 
with fragmented cristae (red arrows). (G-I) Myofibril and mitochondrial integrity of 
parkin mutants is restored by MTF-1 overexpression. Mitochondria are more dense 
(broken white arrows) and muscle structure is more regular (broken green arrows), 
although occasional vacuoles are observed (green arrows). The scale bar is for top and 
middle panels while the bottom panel is at a higher magnification, shown for clarity. 
 
Figure 6. MTF-1 activity is upregulated in a parkin deficient background. Top: 
Transgenic MtnA/EYFP reporter gene (6). Bottom: (A-B) MtnA-EYFP, park25/+ and 
(C-D) MtnA-EYFP, park25/25. Pictures of 1-2 day old adult flies were taken at 730 ms 
exposure with a Leica fluorescence microscope. ‘a’ and ‘p’ show anterior and 
posterior ends, respectively.  
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Figure 7. Increased MTF-1 and metallothionein (MtnB) transcript levels in 
parkin mutants that also express an MTF-1 transgene. Real-time transcript-levels 
of (A) MTF-1, (B) MtnB, (C) parkin and (D) foi in park25/+ and park25/25 and w; tub-
MTF-1, park25/25 and Act-Gal4; UAS-MTF-1; park25/+ and Act-Gal4; UAS-MTF-1; 
park25/25 flies with MTF-1 knockout flies as an appropriate control. All flies were 
raised on normal food (NF). MTF-1 null flies show no MtnB and parkin null flies 
show no parkin transcripts. (B) MTF-1 overexpression from the tubulin 
enhancer/promoter or via the UAS-Act-Gal4 system induced a 234-fold and 270-fold 
increase in MtnB transcripts, respectively. *** indicates significant difference 
between parkin mutant adult flies and parkin mutants with elevated MTF-1 
expression (p<0.0001). 
 
Figure 8. MTF-1 reduces reactive oxygen species (ROS) levels in parkin mutants 
and restores metal homeostasis. (A) park25/25 flies (NF) show high amounts of ROS. 
MTF-1 transgene expression, or treatment with chelators of redox-active metals (BPS 
and BCS) reduce ROS levels. parkin heterozygous controls (park25/+) do not show 
significant differences in ROS levels with or without MTF-1-overexpression or 
dietary supplementation with metal chelators. The MTF-1 knockout shows the highest  
ROS level. ***, p<0.001 and **, p<0.01, chelator-supplemented compared to normal 
food for the same genotype (black stars), or compared to the same treatment between 
genotypes (red stars). (B) Elevated MTF-1 expression in a parkin mutant background 
restores normal basal levels of the essential trace metals copper, iron and zinc when 
flies are raised on NF (normal food). (C) Differences in metal content between 
controls, park25/25 and tub-MTF-1, park25/25 flies are largely leveled out by metal 
supplementation of the food. 
 
Figure 9. Strong expression of human MTF-1 or of Drosophila metallothionein 
prolongs lifespan of parkin mutants. A human-MTF-1 transgene driven by actin-
Gal4 extends the median lifespan of parkin mutant flies from 7 (red) to 19 days (light 
blue). Direct overexpression of metallothionein MtnA by tubulin promoter also 
enhances the median lifespan of parkin mutants up to 17 days (green). An even better 
extension up to a median of 21 days is observed with a tubulin-driven trangene of 
Drosophila MTF-1 (dark blue). park25/+ (black) and park25/25 (red) serve as controls. 
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Table I. (A) Partial rescue of synthetic lethality of combined parkin and MTF-1 
mutants by N-acetylcysteine: MTF-1, parkin heterozygous parents were crossed 
inter se on food supplemented with 15mM NAC. (B) Increased frequency of flies 
reaching adulthood among parkin mutants overexpressing MTF-1. park25/25  
mutants were obtained from parkin heterozygous parents crossed inter se. In both (A) 
and (B), egg laying was allowed for two days by equal numbers of parents and 
eclosing progeny flies were counted thereafter. Three independent crosses were done.  
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Zinc supplement greatly improves the condition of parkin mutant 
Drosophila. 
 
Nidhi Saini1 and Walter Schaffner1. 
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Abstract 
 
Parkinson's disease (PD) is a progressive neurodegenerative disorder in 
which oxidative stress is implicated as a major causative factor. 
Mutations in the gene encoding Parkin, a ubiquitin ligase, are responsible 
for a familial form of PD. In a Drosophila disease model lacking Parkin 
(park(25) null mutant), we tested the effect of zinc supplementation. Zinc 
is an essential trace metal and a component of many enzymes and 
transcriptional regulators. Unlike copper and iron, zinc is not redox-active 
and under most conditions serves as an antioxidant. We find that the 
condition of parkin mutants raised on zinc-supplemented food is greatly 
improved. At zinc concentrations where controls begin to show adverse 
effects as a result of the metal supplement, parkin mutants perform best, 
as manifested in a higher frequency of reaching adulthood, extended 
lifespan and improved motoric abilities. 
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Conclusion and outlook 
 
This work presents several new insights into the interplay between parkin 
and MTF-1 gene products and the beneficial effect of increased zinc in 
parkin mutant flies. The three major advancements outlined here are: (i) 
the extension of lifespan of parkin mutant flies by chelators of redox-
active metals; (ii) characterization of the dramatic rescue effect of MTF-1 
in the parkin deficient flies and (iii) the beneficial effect of zinc in 
ameliorating the effect of a parkin null mutation in Drosophila.  
 
Since it was previously known that parkin mutant Drosophila suffer from 
high oxidative stress, we tested the effect of chelating redox-active metals 
(copper/iron) from the flies. Interestingly, as discussed before, we 
observed a dramatic rescue of the lifespan of the sick flies which 
demonstrated reduced ROS levels. Contrary to our expectations, parkin 
mutant flies fed with food containing high micromolar concentrations of 
redox-active metals like iron or copper did not display any obvious 
detrimental effects beyond their severe condition already observed with 
normal food.  
 
To determine the exact reason why the parkin null Drosophila benefit 
from metal chelation we proceeded to investigate the effects of 
modulating the dosage of MTF-1 which is required for restoring 
homeostasis in a physiologically disturbed cellular system. Further, while 
testing the effect of the essential trace element, zinc on parkin mutants, 
we found the unexpected but nevertheless consistent result that zinc 
supplement ameliorated the parkin mutant phenotype, whereby the parkin 
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mutants seem to sense that high zinc levels help improve the quality of 
their life.  
 
Upon MTF-1 overexpression, we were able to rescue, largely or 
completely, a number of phenotypic traits of a Drosophila model of 
Parkinson's disease, namely; locomotion disability associated with 
distorted muscle/mitochondrial morphology; significantly reduced 
lifespan; female infertility, and low eclosing frequency of parkin mutant 
adults. The metal responsive transcription factor MTF-1 plays a pivotal 
role in modulating the parkin phenotype: flies lacking both MTF-1 and 
parkin are not viable ("synthetic lethality"), while overexpression of 
MTF-1 has strong beneficial effects.  
 
Zinc deprivation by chelation or starvation is known to cause cells to die, 
in many cell types by programmed cell death (Truong-Tran et al., 2001). 
Our results also indicate an imbalance of zinc homeostasis in the parkin 
mutant flies which can be counteracted by zinc supplement. By providing  
food with a high zinc concentration to the parkin mutant flies, we were 
able to rescue a few major phenotypic traits to a significant extent. These 
included an increase in the eclosing frequency of parkin mutant adults, a 
reduced developmental delay and an increased lifespan of mutant adults.  
However, a high zinc concentration in the food, while extending the 
lifespan of parkin mutants, was harmful for the parkin heterozygous 
control flies, as evidenced by a developmental delay and a reduced 
lifespan as well as a decreased propensity of flies to egg-laying. This 
seeming zinc paradox prompted us to investigate the behavioural 
response of both parkin mutants and control flies towards higher zinc 
levels. If the extracellular concentration of zinc exceeds the capacity of 
cellular zinc homeostasis, it becomes cytotoxic and the subsequent 
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increased concentration of intracellular zinc triggers apoptosis 
(Beyersmann, 2002; Beyersmann and Haase, 2001; Choi et al., 1988; 
Duncan et al., 1992; Kim et al., 1999; Walther et al., 2003; Wilhelm et 
al., 2001). Acute zinc toxicity is rare but has been reported (Duncan et al., 
1992) and has been associated with reduced iron absorption and impaired 
immune function (Whittaker, 1998). Excess zinc may also affect the 
cellular status of copper and iron (Prasad et al., 1999). How the zinc leads 
to the improvements in several phenotypes of the mutants and how the 
flies perceive its potential rescue effects are still open questions. Several 
mechanisms are feasible. We propose that extra zinc helps to make up for 
the intrinsic zinc depletion faced by the parkin mutants during 
development, helping them to cope better, most likely by restoring 
several zinc-dependent functions.  
 
Taken together, these data suggest the importance of metal homeostasis 
and antioxidant and stress relieving genes induced by MTF-1 in rescuing 
parkin mutant Drosophila. Hence, therapeutic approaches that modulate 
metal bio-availability might also ameliorate the symptoms of Parkinson’s 
disease. This situation may not even be restricted to Parkinson’s disease 
and might inspire research on novel therapeutic approaches to the other 
neurodegenerative disorders. 
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